Mingteng International H1 2026 loss widens to $7.4M
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Mingteng International Corp Inc. (MTEN), a China-based automotive mold supplier, reported revenue of $5,508,131 for the six months ended June 30, 2026, up 4.7% from $5,261,469 a year earlier. Cost of revenue rose 30.9% to $4,964,045, while gross profit fell 62.9% to $544,086 and gross margin declined to 9.9% from 27.9%. Machining-services revenue rose 46.9% to $1,667,767; mold-production and repair revenue declined 2.5% and 39.6%, respectively.
Operating expenses increased to $7,992,064 from $1,467,073, including research and development expense of $4,894,698 versus $409,623. Net loss was $7,396,495, compared with $1,356,773, and operating activities used $9,402,072 in cash versus $227,053.
At June 30, 2026, cash and cash equivalents were $6,289,189, versus $1,452,992 on December 31, 2025. Financing activities provided $24,128,130, including $22,777,422 of net equity-issuance proceeds. June offerings generated gross proceeds of approximately $2.26 million and $2.96 million, and the company terminated its ATM agreement on June 8 after approximately $20.6 million gross and $18.0 million net proceeds.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointMachining-services revenue rose 46.9% to $1,667,767 in first-half 2026.
Negative
- Major pointNet loss increased 445.2% to $7,396,495 for first-half 2026.
- Major pointOperating activities used $9,402,072 in cash, versus $227,053 in first-half 2025.
- Moderate pointGross profit declined 62.9% to $544,086 in first-half 2026.
Filing Explained
By June 30, the company had paid a $4,500,000 acquisition-related deposit, alongside a $1,000,000 equity-subscription prepayment and $2,266,674 in interest-free third-party loans.
This Form 6-K furnishes the company’s unaudited interim results for the six months ended
The company reported
Key Figures
Key Terms
registered direct offering financial
pre-funded warrants financial
at the market financial
performance obligations financial
right-of-use assets financial
current expected credit losses financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What revenue did MTEN report for the first half of 2026?
How much did MTEN lose in the first half of 2026?
Why did MTEN's gross margin decline in the first half of 2026?
What commission applied to MTEN's terminated ATM agreement?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November
Commission File Number:
(Translation of registrant’s name into English)
No. 10 Fushi Road, Luoshe Town, Huishan District,
Wuxi, Jiangsu Province, China 214000
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
A copy of the Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Six Months Ended June 30, 2026 and 2025 is furnished as Exhibit 99.1, and a copy of the Interim Financial Statements is furnished as Exhibit 99.2 to this report on Form 6-K.
1
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Six Months Ended June 30, 2026 and 2025 | |
| 99.2 | Unaudited Interim Condensed Consolidated Financial Statements for the Six Months ended June 30, 2026 and 2025 | |
| 101.INS | Inline XBRL Instance Document. | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: November 13, 2026 | Mingteng International Corporation Inc. | |
| By: | /s/ Yingkai Xu | |
| Name: | Yingkai Xu | |
| Title: | Chief Executive Officer | |
3
Exhibit 99.1
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes thereto. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs that involve risks and uncertainties. As a result of many important factors, our actual results and the timing of events may differ materially from those anticipated in these forward-looking statements. All amounts included herein with respect to the six months ended June 30, 2026 and 2025 are derived from our unaudited condensed consolidated financial statements in this filing. Our financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles, or U.S. GAAP.
Throughout this report, unless the context indicates otherwise, any references to “Mingteng International,” “we,” “us,” “our Company,” “the Company,” and “our” are to Mingteng International Corporation Inc., a Cayman Islands holding company, and when describing Mingteng International’s consolidated financial information for the six months ended June 30, 2026 and the fiscal years December 31, 2025, also includes Mingteng International’s subsidiaries. References to “PRC Subsidiaries” refer to Mingteng International’s subsidiaries established under the laws of the People’s Republic of China. Unless otherwise indicated, in this annual report, references to:
| ● | “China” or the “PRC” refers to the People’s Republic of China. | |
| ● | “Class A Ordinary Shares” refers to the Class A ordinary shares of Mingteng International with par value $0.00005 per share. | |
| ● | “Class B Ordinary Shares” refers collectively to the Class B ordinary shares of Mingteng International with par value $0.00005 per share. | |
| ● | “Ordinary Shares” refers collectively to the Class A ordinary shares and Class B ordinary shares of Mingteng International with par value $0.00005 per share. | |
| ● | “RMB” refers to Renminbi, the legal currency of the PRC. | |
| ● | “U.S. dollars,” “$” and “USD” refers to the legal currency of the United States. | |
| ● | “Mingteng HK” refers to Mingteng International Hong Kong Group Limited, an entity incorporated under the laws and regulations in Hong Kong and a wholly owned subsidiary of Mingteng International. | |
| ● | “Ningteng WFOE” refers to Wuxi Ningteng Intelligent Manufacturing Co., Ltd., a limited liability company organized under the laws of the PRC and a wholly owned subsidiary of Mingteng HK. | |
| ● | “WFOE” refers to a wholly foreign-owned enterprise. | |
| ● | “Wuxi Mingteng Mould” refers to Wuxi Mingteng Mould Technology Co., Ltd., a limited liability company organized under the laws of the PRC and a wholly owned subsidiary of Ningteng WFOE. |
Overview
We are a holding company incorporated in the Cayman Islands with operations conducted in China by our PRC subsidiary, Wuxi Mingteng Mould, incorporated in the PRC. We are an automotive mold developer and supplier in China. Wuxi Mingteng Mould was established in December 2015, focusing on molds used in auto parts. We are committed to providing customers with comprehensive and personalized mold services, covering mold design and development, mold production, assembly, testing, repair and after-sales service.
We provide a wide variety of products. Our main products are casting molds for turbocharger systems, braking systems, steering and differential system, and other automotive system parts.
We also produce molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobiles, construction machinery and other manufacturing industries.
Our production plant is located in Wuxi, China. We use technologically advanced procedures and equipment to produce molds. We use a mold manufacturing processing center, which allocates different machines to manufacture according to the size of the mold and the shape of the accessories. Our mold development and production process are supported by our research and development (“R&D”) team (including experts such as foundry technologists and mold designers), using advanced Computer Aided Design (“CAD”), Computer Aided Manufacturing (“CAM”) and software technologies to analyze feasibility and validity of mold designs and specifications. Our quality and capability have obtained the 2019 Jiangsu High-tech Enterprise Certification (extended to 2028) and ISO9001:2015 certification.
In order to improve our technical level and service quality, we are committed to developing and producing molds through technological innovation. We believe that the design and quality of our molds are extremely important to the accuracy and efficiency of our customers’ manufacturing processes. Our existing technical team consists of 19 people, all with professional knowledge in casting, machining, and automation. They analyze customers’ casting and processing technology, propose solutions and improvement suggestions to customers to enhance the efficiency and safety of their products. In addition, we believe our research and patents in the field of automotive casting molds have earned us recognition from our customers, and we have registered 26 authorized utility model and invention patents in China.
We are a supplier to a number of Chinese listed companies and have established long-term business relationships with leading major customers in the automobile parts manufacturing industry, most of whom have more than 5 years of business relationship with us. Our customers include Kehua Holding Co., Ltd. (ticker: 603161), Wuxi Lihu Booster Technology Co., Ltd. (ticker: 300694), and Wuxi Best Precision Machinery Co., Ltd. (ticker: 300580). Our close relationships with these major customers demonstrate our strengths in technical capabilities, service reputation and product quality.
Our revenue mainly comes from customized mold production, mold repair and machining services. The revenue derived from customized mold production accounted for 64.3% and 69.1% of our total revenue for the six months ended June 30, 2026 and 2025, respectively. The revenue derived from mold repair accounted for 5.4% and 9.3% of our total revenue for the six months ended June 30, 2026 and 2025, respectively. The revenue derived from machining services accounted for 30.3% and 21.6% of our total revenue for the six months ended June 30, 2026 and 2025, respectively.
2
Our organization
The following chart shows our current corporate structure:

Mingteng International was incorporated under the laws of the Cayman Islands on September 20, 2021, as an exempt company with limited liability.
Mingteng International owns a 100% equity interest in Mingteng HK, an entity incorporated on November 4, 2021, in accordance with the laws and regulations in Hong Kong. Mingteng HK is a holding company and is not actively engaged in any business.
Ningteng WFOE was incorporated on September 6, 2022, under the laws of the PRC. Ningteng WOFE is a wholly owned subsidiary of Mingteng HK and is not actively engaged in any business.
Wuxi Mingteng Mould is a limited liability company incorporated on December 15, 2015, under the laws of the PRC. Wuxi Mingteng Mould is a wholly owned subsidiary of Ningteng WFOE and is our operating entity. Wuxi Mingteng Mould is primarily engaged in providing clients with comprehensive and personalized mold services and solutions in the PRC, including mold design and development; mold production, repair, testing and adjustment.
Recent Developments
Change in Class B Ordinary Shares Voting Rights and Share Capital
On May 29, 2026, the Company held a meeting of the holders of Class A Ordinary Shares, and the holders of Class A Ordinary Shares approved the variation of the rights attaching to the Class A Ordinary Shares arising from the proposed increase in the voting rights of the Class B Ordinary Shares and the adoption of the Fourth Amended and Restated Memorandum and Articles of Association. At the subsequent annual general meeting held on the same date, the shareholders approved (i) an increase in the voting rights attached to the Class B Ordinary Shares, (ii) a reduction in the par value of the Company’s ordinary shares, (iii) an increase in the Company’s authorized share capital, and (iv) the adoption of the Fourth Amended and Restated Memorandum and Articles of Association reflecting such changes.
3
June 2026 Registered Direct Offering
On June 9, 2026, we entered into a securities purchase agreement with certain institutional investors pursuant to which we agreed to issue and sell, in a registered direct offering, (i) an aggregate of 501,834 Class A Ordinary Shares at an offering price of US$2.00 per Class A Ordinary Share, and (ii) pre-funded warrants to purchase up to an aggregate of 629,170 Class A Ordinary Shares (the “Pre-Funded Warrants”) at an offering price of US$1.99995 per Pre-Funded Warrant, which equals the offering price per Class A Ordinary Share minus the exercise price of US$0.00005 per share of the Pre-Funded Warrants. The offering was made pursuant to our registration statement on Form F-3 (File No. 333-287843), initially filed with the SEC with and declared effective on November 18, 2025, the base prospectus included therein and a prospectus supplement dated June 10, 2026.
The offering was closed on June 10, 2026. We received gross proceeds of approximately US$2.26 million, before deducting placement agent fees and other offering expenses. All of the Pre-Funded Warrants were exercised in full on June 9, 2026, and we issued an aggregate of 629,170 Class A Ordinary Shares upon their exercise on June 10, 2026. We intend to use the proceeds from the offering for working capital and general corporate purposes.
Termination of the ATM Agreement
On December 4, 2025, we entered into a sales agreement (the “Sales Agreement”) with AC Sunshine Securities LLC, as sales agent, pursuant to which we may offer and sell from time to time, in “at the market” offerings, Class A Ordinary Shares having an aggregate offering price of up to US$100,000,000. The offering under the Company’s effective shelf registration statement on Form F-3 (File No. 333-287843) and the related prospectus supplement dated December 8, 2025.
As of June 8, 2026, we had issued and sold an aggregate of 222,568,877 Class A Ordinary Shares under the Sales Agreement, and received gross proceeds of approximately US$20.6 million. After paying the sales agent a commission of 3.5% of the gross proceeds and certain other offering expenses, we received net proceeds of approximately US$18.0 million. The Sales Agreement was terminated as of June 8, 2026. We intend to use the net proceeds from the offering for general corporate purposes, including working capital, business development initiatives and capital expenditures.
June 2026 Registered Direct Offering and Concurrent Private Placement
On June 17, 2026, we entered into a securities purchase agreement with certain institutional investors pursuant to which we agreed to issue and sell, in a registered direct offering, (i) an aggregate of 457,355 Class A Ordinary Shares at an offering price of US$2.00 per Class A Ordinary Share, and (ii) pre-funded warrants to purchase up to an aggregate of 1,022,645 Class A Ordinary Shares (the “June 2026 Pre-Funded Warrants”) at an offering price of US$1.99995 per June 2026 Pre-Funded Warrant, which equals the offering price per Class A Ordinary Share minus the exercise price of US$0.00005 per share of the June 2026 Pre-Funded Warrants. The registered direct offering was made pursuant to our registration statement on Form F-3 (File No. 333-287843), initially filed with the SEC and declared effective on November 18, 2025, the base prospectus included therein and a prospectus supplement dated June 17, 2026. In a concurrent private placement, we also agreed to issue and sell to the same investors unregistered warrants to purchase up to an aggregate of 1,480,000 Class A Ordinary Shares (the “Private Warrants”) at an exercise price of US$2.00 per Class A Ordinary Share. The Private Warrants are exercisable upon issuance and will expire eighteen months from the date of issuance. The Private Warrants were issued pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.
The registered direct offering and the concurrent private placement closed on June 18, 2026. We received gross proceeds of approximately US$2.96 million, before deducting placement agent fees and other offering expenses. We intend to use the proceeds from these offerings for working capital and general corporate purposes.
Waiver Agreement and Registration Rights Agreement
On June 29, 2026, we entered into a waiver agreement (the “Waiver Agreement”) and a registration rights agreement (the “Registration Rights Agreement”) with certain investors who had purchased Class A Ordinary Shares from us under a securities purchase agreement dated April 13, 2026 (the “April 2026 SPA”), which closed on April 17, 2026. Under the April 2026 SPA, the Class A Ordinary Shares purchased by these investors were subject to a lock-up restriction for a period of 180 days following the closing. Pursuant to the Waiver Agreement, we waived this lock-up restriction effective as of June 29, 2026. The waiver applies solely to the contractual lock-up restriction under the April 2026 SPA, and any transfer or resale of these Class A Ordinary Shares remains subject to applicable securities laws, including Rule 144 and Regulation S under the Securities Act.
4
Pursuant to the Registration Rights Agreement, we were required to file with the SEC, on or prior to the date that is 180 calendar days following June 29, 2026, a registration statement on Form F-1 or Form F-3, as applicable, covering the resale of the Class A Ordinary Shares purchased under the April 2026 SPA that are not then registered on an effective registration statement.
Such resale registration statement on Firm F-1 was filed on July 20, 2026 and was declared effective on August 3, 2026.
Factors Affecting Our Results of Operations
Changes in the availability, quality and cost of key raw materials, transportation and other necessary supplies or services
Our raw materials consist primarily of steel plates and casting. The cost of raw materials represents a significant portion of our total cost of revenues.
Raw material costs represent 32.3% and 28.3% of our total cost of revenues for the six months ended June 30, 2026 and 2025, respectively.
We are exposed to fluctuations in the prices of raw materials, transportation, and other necessary supplies or services due to factors beyond our control, such as policies, inflation, and changes in the supply and demand for such relevant raw materials. We may not be able to offset the price increases by increasing our product prices, in which case our margins would decline, and our financial condition and results of operations could be materially and adversely affected. In addition, if we significantly increase the prices of our products, we may lose our competitive advantage. This in turn could result in a loss of sales and customers. In either case, our business, financial condition, and results of operations could be materially and adversely affected.
Our business is dependent on certain major customers and changes or difficulties in our relationships with our major customers may harm our business and financial results.
For the six months ended June 30, 2026 and 2025, ten major customers accounted for approximately 82.2% and 80.3% of our total sales, respectively. Any decrease in sales to these major customers may negatively impact on our operations and cash flows if we fail to increase its sales to other customers.
As of June 30, 2026 and December 31, 2025, ten major customers accounted for approximately 75.6% and 80.3% of our accounts receivable balance, separately.
If we cannot maintain long-term relationships with our major customers or replace major customers from period to period with equivalent customers, the loss may negatively impact our business, financial condition, and results of operations. If our customer base decreases, we may not be able to generate sufficient revenue to cover our increased costs and expenses. As a result, our business and results of operations may be materially and adversely affected.
Our business is related to the development of upstream and downstream industries.
Mold production is closely related to the development of upstream and downstream industries. With the gradual saturation of the Chinese automotive market, the production of molds related to auto parts may be affected.
Results of Operations
Comparison of Results of Operations for the Six Months Ended June 30, 2026 and 2025
The following table summarizes our results of unaudited operations for the six months ended June 30, 2026 and 2025, respectively, and provides information regarding the dollar and percentage increase or (decrease) during such periods.
5
(UNAUDITED)
| For the Six Months Ended June 30, | ||||||||||||||||||||||||
| 2026 | 2025 | Variance | ||||||||||||||||||||||
| Amount | % of revenue | Amount | % of revenue | Amount | % | |||||||||||||||||||
| Revenues | $ | 5,508,131 | 100.0 | % | $ | 5,261,469 | 100.0 | % | $ | 246,662 | 4.7 | % | ||||||||||||
| Cost of revenues | (4,964,045 | ) | (90.1 | )% | (3,793,049 | ) | (72.1 | )% | (1,170,996 | ) | 30.9 | % | ||||||||||||
| Gross profit | 544,086 | 9.9 | % | 1,468,420 | 27.9 | % | (924,334 | ) | (62.9 | )% | ||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||
| Selling expenses | (226,705 | ) | (4.1 | )% | (53,764 | ) | (1.0 | )% | (172,941 | ) | 321.7 | % | ||||||||||||
| General and administrative expenses | (2,870,661 | ) | (52.1 | )% | (1,003,686 | ) | (19.1 | )% | (1,866,975 | ) | 186.0 | % | ||||||||||||
| Research and development expenses | (4,894,698 | ) | (88.9 | )% | (409,623 | ) | (7.8 | )% | (4,485,075 | ) | 1094.9 | % | ||||||||||||
| Total operating expenses | (7,992,064 | ) | (145.1 | )% | (1,467,073 | ) | (27.9 | )% | (6,524,991 | ) | 444.8 | % | ||||||||||||
| (Loss) income from operations | (7,447,978 | ) | (135.2 | )% | 1,347 | 0.0 | % | (7,449,325 | ) | (553,030.8 | )% | |||||||||||||
| Other income (expenses): | ||||||||||||||||||||||||
| Government subsidies | 57,595 | 1.0 | % | 64,728 | 1.2 | % | (7,133 | ) | (11.0 | )% | ||||||||||||||
| Interest income | 1,068 | 0.0 | % | 688 | 0.0 | % | 380 | 55.2 | % | |||||||||||||||
| Interest expense | (29,254 | ) | (0.5 | )% | (22,518 | ) | (0.4 | )% | (6,736 | ) | 29.9 | % | ||||||||||||
| Other-Than-Temporary Impairment | - | - | % | (1,356,618 | ) | (25.8 | )% | 1,356,618 | (100.0 | )% | ||||||||||||||
| Other (expenses) income, net | (7,104 | ) | (0.1 | )% | 16,812 | 0.3 | % | (23,916 | ) | (142.3 | )% | |||||||||||||
| Total other income(expenses), net | 22,305 | 0.4 | % | (1,296,908 | ) | (24.6 | )% | 1,319,213 | (101.7 | )% | ||||||||||||||
| Loss before income taxes | (7,425,673 | ) | (134.8 | )% | (1,295,561 | ) | (24.6 | )% | (6,130,112 | ) | 473.2 | % | ||||||||||||
| Benefit from (Provision for) income taxes | 29,178 | 0.5 | % | (61,212 | ) | (1.2 | )% | 90,390 | (147.7 | )% | ||||||||||||||
| Net loss | $ | (7,396,495 | ) | (134.3 | )% | $ | (1,356,773 | ) | $ | (25.8 | )% | $ | (6,039,722 | ) | 445.2 | % | ||||||||
6
Revenue
Currently, we have three revenue streams: mold production, mold repair and machining services.
Total revenue for the six months ended June 30, 2026 increased by $246,662, or 4.7%, to $5,508,131 from $5,261,469 for the same period in 2025.
The following table sets forth the breakdown of our unaudited revenue for the six months ended June 30, 2026 and 2025, respectively:
(UNAUDITED)
| For the Six Months Ended June 30, | ||||||||||||||||||||||||
| 2026 | 2025 | Variance | ||||||||||||||||||||||
| Amount | % | Amount | % | Amount | % | |||||||||||||||||||
| Mold production | $ | 3,543,601 | 64.3 | % | $ | 3,634,475 | 69.1 | % | $ | (90,874 | ) | (2.5 | )% | |||||||||||
| Mold repair | 296,763 | 5.4 | % | 491,454 | 9.3 | % | (194,691 | ) | (39.6 | )% | ||||||||||||||
| Machining services | 1,667,767 | 30.3 | % | 1,135,540 | 21.6 | % | 532,227 | 46.9 | % | |||||||||||||||
| Total | $ | 5,508,131 | 100.0 | % | $ | 5,261,469 | 100.0 | % | $ | 246,662 | 4.7 | % | ||||||||||||
Revenues from mold production. Revenues from mold production accounted for 64.3% and 69.1% of our total revenues for the six months ended June 30, 2026 and 2025, respectively. Revenue from mold production decreased by $90,874, or 2.5% from $3,634,475 for the six months ended June 30, 2025 to $3,543,601 for the same period in 2026. The decrease was primarily due to a reduction in average selling prices resulting from intensified market competition. Although we experienced an increase in sales volume, the price reduction outpaced the volume growth, leading to a net decrease in total revenue. We will continue to monitor market conditions and will adjust our pricing strategy as appropriate.
Revenues from mold repair. Revenues from mold repair accounted for 5.4% and 9.3% of our total revenues for the six months ended June 30, 2026 and 2025, respectively. Revenues from mold repair decreased by $194,691, or 39.6% from $491,454 for the six months ended June 30, 2025 to $296,763 for the same period in 2026. The decrease was primarily attributable to a decline in both sales volume and average selling prices, driven by intensified market competition and softened customer demand during the period.
Revenues from machining services. Revenues from machining services accounted for 30.3% and 21.6% of our total revenues for the six months ended June 30, 2026 and 2025, respectively. Revenues from machining services have significantly increased by $532,227, or 46.9% from $1,135,540 for the six months ended June 30, 2025 to $1,667,767 for the same period in 2026. The increase was primarily driven by higher sales volume resulting from growing customer demand. Kehua Holding Co., Ltd. and Suzhou Lvkon Transmission Technology Co., Ltd. are our major customers in machine services.
Cost of Revenues
The following table sets forth the breakdown of our unaudited cost of revenue for the six months ended June 30, 2026 and 2025, respectively:
(UNAUDITED)
| For the Six Months Ended June 30, | ||||||||||||||||||||||||
| 2026 | 2025 | Variance | ||||||||||||||||||||||
| Amount | % | Amount | % | Amount | % | |||||||||||||||||||
| Mold production | $ | 3,220,198 | 64.9 | % | $ | 2,704,880 | 71.3 | % | $ | 515,318 | 19.1 | % | ||||||||||||
| Mold repair | 279,912 | 5.6 | % | 215,256 | 5.7 | % | 64,656 | 30.0 | % | |||||||||||||||
| Machining services | 1,463,935 | 29.5 | % | 872,913 | 23.0 | % | 591,022 | 67.7 | % | |||||||||||||||
| Total | $ | 4,964,045 | 100.0 | % | $ | 3,793,049 | 100.0 | % | $ | 1,170,996 | 30.9 | % | ||||||||||||
7
The cost of revenues increased by $1,170,996, or 30.9%, to $4,964,045 for the six months ended June 30, 2026, from $3,793,049 for the same period in 2025. cost of revenues mainly comes from raw material costs, manufacturing costs and labor costs.
The total revenue has increased by 4.7%, but the total cost of revenue has increased by 30.9%, the reasons for the cost increase much more than revenue are as follows:
Firstly, due to the increase in order volume, the material costs increased by $499,053 from $1,080,316 for the six months ended June 30, 2025 to $1,579,369 for the same period in 2026.
Secondly, in order to promote the future development of machining services and expand production capacity, we hired more production labor for the six months ended June 30, 2026, which led to an increase in labor cost of $211,887 compared with the same period in 2025.
Lastly, the increase in the manufacturing cost by $345,413 compared with the same period for the six months ended June 30, 2026. In order to pursue the future development of the aluminum alloy pressure casting mold business and machining service and expand production capacity, the total investment of production machinery and equipment for the six months ended June 30, 2026 and 2025 was $501,250 and $118,899, respectively, resulting in an increase in depreciation expense which allocated to production costs of $108,880. The depreciation expense has increased to $338,665 for the six months ended June 30, 2026 compared with $229,785 for the six months ended June 30, 2025. In addition, leasing cost increased by $201,731 for the six months ended June 30, 2026, primarily due to the relocation of our production facilities.
Gross Profit
Total gross profit was $544,086 for the six months ended June 30, 2026, a decrease of $924,334 from $1,468,420 for the same period in 2025. Gross profit margin declined by 18.0%, to 9.9% for the six months ended June 30, 2026, from 27.9% for the same period in 2025.
Our gross profit and gross profit margin by product types were as follows:
(UNAUDITED)
| For the Six Months Ended June 30, | ||||||||||||||||||||||||
| 2026 | 2025 | Variance | ||||||||||||||||||||||
| Gross profit | Margin % | Gross profit | Margin % | Gross profit | Margin % | |||||||||||||||||||
| Mold production | $ | 323,403 | 9.1 | % | $ | 929,595 | 25.6 | % | $ | (606,192 | ) | (65.2 | )% | |||||||||||
| Mold repair | 16,851 | 5.7 | % | 276,198 | 56.2 | % | (259,347 | ) | (93.9 | )% | ||||||||||||||
| Machining services | 203,832 | 12.2 | % | 262,627 | 23.1 | % | (58,795 | ) | (22.4 | )% | ||||||||||||||
| Total | $ | 544,086 | 9.9 | % | $ | 1,468,420 | 27.9 | % | $ | (924,334 | ) | (62.9 | )% | |||||||||||
Gross profit for mold production decreased by $606,192 to $323,403 for the six months ended June 30, 2026, as compared to $929,595 for the same period in 2025. The manufacturing costs, labor costs and the depreciation expense collocated to cost of sales all increased due to expanded production scale, which resulted in increase in total cost of sales. Costs increased at a greater rate than the increase in revenue for the six months ended June 30, 2026 compared with the same period in 2025, which led to the decrease in gross profit and gross profit margin. Mold production is the main source of revenue of us, due to an increase in order volume in the first half of 2026 compared to the first half of 2025, the total cost of sales increased by 19.1% which adversely affected the profit margin of mold production business. Due to the fact that mold production remains the main source of revenue for us, the increase in manufacturing costs and labor costs absorption was the largest. As the mold production industry market competition intensifies, we reduced the selling price of our products to maintain our competitive advantage despite rising product costs, which resulted in a decline in gross profit.
8
Gross profit for mold repair decreased by $259,347 to $16,851 for the six months ended June 30, 2026, as compared to $276,198 for the same period in 2025. similar to the mold production, affected by market conditions, we have had no choice but to lower our selling prices. Furthermore, the growth in fixed costs has resulted in a substantial decrease in gross profit.
Gross profit for machining services decreased by $58,795 to $203,832 for the six months ended June 30, 2026, as compared to $262,627 for the same in 2025. The decrease in the gross profit was mainly due to the growth in fixed costs and higher raw material costs.
Operating Expenses
(UNAUDITED)
| For the Six Months Ended June 30, | ||||||||||||||||||||||||
| 2026 | 2025 | Variance | ||||||||||||||||||||||
| Amount | % | Amount | % | Amount | % | |||||||||||||||||||
| Selling expenses | $ | 226,705 | 2.8 | % | $ | 53,764 | 3.7 | % | $ | 172,941 | 321.7 | % | ||||||||||||
| General and administrative expenses | 2,870,661 | 36.0 | % | 1,003,686 | 68.4 | % | 1,866,975 | 186.0 | % | |||||||||||||||
| Research and development expenses | 4,894,698 | 61.2 | % | 409,623 | 27.9 | % | 4,485,075 | 1,094.9 | % | |||||||||||||||
| Total operating expenses | $ | 7,992,064 | 100.0 | % | $ | 1,467,073 | 100.0 | % | $ | 6,524,991 | 444.8 | % | ||||||||||||
Selling Expenses
Selling expenses were $226,705 for the six months ended June 30, 2026, an increase of $172,941, or 321.7%, from $53,764 for the same period in 2025. This increase is mainly attributable to the a) in the second half of 2025, the Company entered into an agreement with third-party companies, pursuant to which the third-party companies introduced clients to the Company and charged referral fees, resulting in an increase of $155,197 in related expenses; b) business entertainment expenses increased by $13,581 for the six months ended June 30, 2026 compared with the same period in 2025.
General and Administrative Expenses
Our general and administrative expenses were $2,870,661 for the six months ended June 30, 2026, an increase of $1,866,975 or 186.0%, from $1,003,686 for the same period in 2025. The increase was mainly due to the a) an increase of share-based compensation $1,459,200 to personnel engaged in general and administrative functions; b) increase of consulting fee for the six months ended June 30, 2026 by $358,872 compared with the same period in 2025.
Research and Development Expenses
Research and development expenses increased by $4,485,075, or 1,094.9%, to $4,894,698 for the six months ended June 30, 2026, from $409,623 for the same period in 2025. This increase was mainly attributable to newly added R&D projects entrusted to third-party companies, with an increase of $4,553,800.
9
Other income
Government subsidies
We receive various government subsidies from time to time, such as the “The High-Tech Enterprise Cultivation Award” and “Technology Development Support Grant.”, we cannot predict the likelihood or amount of any future subsidies.
For the six months ended June 30, 2026, government subsidies were $57,595. For the same period in 2025, government subsidies were $64,728.
Interest income
For the six months ended June 30, 2026, interest income was $1,068, increased by $380 as compared with the same period in 2025, interest income was $688. This is mainly due to the increase in average bank deposits during the six months ended June 30, 2026 compared to the same period in 2025.
Interest expense
For the six months ended June 30, 2026, interest expense was $29,254. For the same period in 2025, interest expense was $22,518, the increase of $6,736 mainly due to the increase in average bank loans for the six months ended June 30, 2026 compared with the same period in 2025.
Other-than-temporary impairment
For the six months ended June 30, 2026, we recorded an other-than-temporary impairment of nil compared to $1,356,618 for the same period in 2025. This impairment was due to the fact that the original agreed investment and operation plan was no longer executed by the executives of Planty Holding Limited (“Planty”), which indicated a severe and sustained adverse impact on Planty’s expected profitability, and management therefore determined that the fair value of the investment in Planty should be written down to nil.
Other (expenses) income, net
For the six months ended June 30, 2026, other expenses, net was $7,104. For the same period in 2025, other income, net was $16,812, a decrease of $23,916 or 142.3%.
Benefit from (provision for) Income Taxes
Our benefit from income taxes was $29,178 for the six months ended June 30, 2026, a decrease of $90,390, or 147.7% from provision for income taxes was $61,212 for the same period in 2025. The decrease was mainly due to the decrease in pre-tax profits.
Under the Enterprise Income Tax (“EIT”) Law of the PRC, domestic enterprises are usually subject to a unified 25% EIT rate while preferential tax rates, tax holidays, and even tax exemptions may be granted on a case-by-case basis. The PRC tax authorities grant preferential tax treatment to High and New Technology Enterprises (“HNTEs”). Under this preferential tax treatment, HNTEs are entitled to an income tax rate of 15%, subject to a requirement that they re-apply for HNTE status every three years. Since Wuxi Mingteng Mould was approved as an HNTE in December 2019, Wuxi Mingteng Mould is entitled to a reduced income tax rate of 15% beginning December 2019 and is able to enjoy the reduced income tax rate through December 2022. In November 2022, Wuxi Mingteng Mould reapplied to obtain the recognition of HNTE and the preferential rate of 15% was extended to November 2025. In November 2025, Wuxi Mingteng Mould reapplied and obtained the recognition of HNTE and the preferential rate of 15% was extended to November 2028.
10
Net Loss
As a result of the foregoing, our net loss for the six months ended June 30, 2026 was $7,396,495, and for the same period in 2025, the net loss was $1,356,773.
Liquidity and Capital Resources
As of June 30, 2026 and December 31, 2025, we had cash and cash equivalents of $6,289,189 and $1,452,992, respectively.
Our main sources of operating funds are from equity financing and external borrowings, and we are confident they are sufficient to sustain our operations after the offering.
Working Capital
Total working capital as of June 30, 2026 amounted to $13,064,464 compared to $1,554,211 as of December 31, 2025. The current assets increase mainly due to the increase in cash and cash equivalents of $4,836,197, short-term investments of $1,851,123, advance to supplier of $5,155,761, and other receivables of $1,783,212. Current liabilities amounted to $10,418,914 as of June 30, 2026 as compared to $8,301,487 as of December 31, 2025. This increase in liabilities was attributable mainly to the increases in short-term loans of $1,513,751, and accounts payable of $745,151.
Capital Needs
Our capital needs include our daily operating needs and capital expenditure. With the uncertainty of the current market our management believes it is necessary to enhance the collection of outstanding accounts receivable and other receivables and to be cautious on operational decisions and project selection. We review the accounts receivable on a periodic basis and make general and specific allowances when there is doubt as to the recoverability of individual balances. Our management is confident in the collection of account receivables and other receivables.
Cash Flows Analysis
Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025
The following table sets forth a summary of our unaudited cash flows for the periods indicated:
(UNAUDITED)
| For the Six Months Ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| Net cash used in operating activities | $ | (9,402,072 | ) | $ | (227,053 | ) | ||
| Net cash used in investing activities | (9,929,944 | ) | (295,389 | ) | ||||
| Net cash provided by financing activities | 24,128,130 | 190,000 | ||||||
| Effect of foreign exchange rate on cash and cash equivalents | 40,083 | 6,932 | ||||||
| Net increase (decrease) in cash and cash equivalents | 4,836,197 | (325,510 | ) | |||||
| Cash and cash equivalents at the beginning of the period | 1,452,992 | 2,080,715 | ||||||
| Cash and cash equivalents at the end of the period | $ | 6,289,189 | $ | 1,755,205 | ||||
Operating Activities
Net cash used in operating activities amounted to $9,402,072 for the six months ended June 30, 2026. It was primarily due to a) a net loss of $7,396,495, adjusted by depreciation of $398,296, b) amortization of intangible assets and right-of-use assets of $203,660, c) share-based compensation expenses of $1,459,200, d) deferred income tax benefits of $29,178, e) provision for credit losses of $24,400, f) provision for contract costs impairment of $7,465. g) increase in other receivables-bank acceptance notes of $561,116, h) decrease in account receivable of $844,750, i) increase in advances to suppliers of $5,150,578, j) decrease in other receivables of $20,562, k) increase in inventories of $122,678 due to the expansion of order volume, l) increase in accounts payable of $1,025,251, m) decrease in advance from customers of $15,751, n) increase in payroll payable of $58,258 due to the social security and public housing funding, and the salary for independent directors, etc.
11
Net cash used in operating activities amounted to $227,053 for the six months ended June 30, 2025. It was primarily due to a) a net loss of $1,356,773, adjusted by depreciation of $282,373, b) amortization of intangible assets and right-of-use assets of $17,867, c) deferred income tax of $6,493, d) provision for credit losses of $3,907, e) impairment loss on long-term investment of $1,356,618, f) provision for contract costs impairment of $13,165. g) increase in other receivables-bank acceptance notes of $726,008, h) decrease in account receivable of $245,175, i) decrease in advances to suppliers of $47,880, j) increase in inventories of $295,816 due to the expansion of order volume, k) increase in accounts payable of $102,825, l) decrease in advance from customers of $214,530, m) increase in payroll payable of $192,941 due to the social security and public housing funding, and the salary for independent directors, n) increase in other payable of $49,182 due to the unpaid fees, etc.
Investing Activities
Net cash used in investing activities amounted to $9,929,944 for the six months ended June 30, 2026. It was primarily due to a) purchase of property and equipment amount of $781,362, b) purchases of intangible assets amount of $63,867, c) purchase short-term investments of $2,983,966, d) maturities of short-term investments of $1,165,925, e) interest-free loan to third parties of $2,266,674; f) prepayment for equity subscription of $1,000,000; g) prepayment for acquisition related deposits of $4,500,000; h) repayment of interest-free loan to third parties of $500,000.
Net cash used in investing activities amounted to $295,389 for the six months ended June 30, 2025. It was primarily due to purchase of property and equipment.
Financing Activities
Net cash provided by financing activities was $24,128,130 for the six months ended June 30, 2026. During the first half of 2026, we received net proceeds from short-term loans of $1,450,708, cash receipts from equity issuance, net of issuance cost of $22,777,422, repayments of third party loans of $100,000.
Net cash provided by financing activities was $190,000 for the six months ended June 30, 2025. During the first half of 2025, we received proceeds from third party loans of $190,000.
Loan Facilities
On February 21, 2024, we renewed the unsecured short-term loan agreement with Bank of Jiangsu with principal amount of RMB 10 million (approximately $1.4 million), with an annual interest rate of 2.95%. The maturity date of the loan is February 20, 2025.
On February 18, 2025, we entered into an additional secured short-term loan agreement with Bank of Jiangsu with principal amount of RMB 10 million (approximately $1.4 million), with an annual interest rate of 3.30%. The maturity date of the loan is February 17, 2026.
On December 18, 2025, Wuxi Mingteng Mould entered into a short-term loan agreement with Bank of Jiangsu with principal amount of approximately $1.4 million, with an annual interest rate of 2.30% and maturity date as of December 17, 2026
On January 14, 2026, Wuxi Mingteng Mould received a short-term loan of approximately $0.71 million from China Merchants Bank with the initial loan interest rate of 2.25%. The interest rate is a floating rate based on LPR, reduced by 75 basis points, with a repricing period of three months. The maturity date of the loan is January 14, 2027.
On March 5, 2026, Wuxi Mingteng Mould received a short-term loan of approximately $0.71 million from China CITIC Bank with the initial loan interest rate of 2.4%. The maturity date of the loan is March 5, 2027.
12
Contingencies
From time to time, we may be subject to certain legal proceedings, claims and disputes that arise in the ordinary course of business. Amounts accrued, as well as the total amount of possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements. As of June 30, 2026, we have no outstanding litigation.
Off-Balance Sheet Arrangements
We have not entered into any financial guarantees or other commitments to guarantee the payment obligations of any third parties. In addition, we have not entered into any derivative contracts that are indexed to our own shares and classified as shareholders’ equity, or that are not reflected in our financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. Moreover, we do not have any variable interest in an unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.
Inflation
Inflationary factors, such as increases in the cost of raw materials, personnel and overhead costs, could impair our operating results. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, a high rate of inflation in the future may have an adverse effect on our ability to maintain current levels of gross margin and operating expenses if the revenues from our products do not increase with such increased costs. We source key materials from third parties located in China. Although China has not experienced significant inflation and thus inflation has not had a material impact on our results of operations, we cannot provide any assurances that we will not be affected in the future by higher rates of inflation in mainland China. Sustained or rising inflation may result in increased costs to us in obtaining supplies of key materials to produce our products. If we explore the international market in the future, inflation may affect us by increasing our cost of labor and freight costs for our exported products. As a result, our results of operations may be adversely impacted.
Our plan to mitigate inflationary pressures are as follows: 1) control the growth of external costs by locking in prices and buying in bulk; 2) consider user experience and profitability, strengthen communication with customers, and adjust our pricing strategy to meet cost increases; and 3) strengthen internal management and technology research, to improve production efficiency and reducing the waste of production resources.
Supply Chain Analysis
For the six months ended June 30, 2026, two suppliers accounted for approximately 39.3% and 30.6% of the total purchases. For the six months ended June 30, 2025, two suppliers accounted for approximately 13.3%, and 10.3% of the total purchases.
The raw materials used in production are mainly universal, such as steel and castings, which are highly replaceable and have a wide range of procurement sources. Therefore, we do not have nor anticipate a major dependence on suppliers, and the loss of some suppliers will not have a significant impact on our production.
Seasonality
The nature of our business does not appear to be affected by seasonal variations.
Critical Accounting Policies.
We prepare our consolidated financial statements in accordance with U.S. GAAP. These accounting principles require us to make judgments, estimates and assumptions on the reported amounts of assets and liabilities at the end of each fiscal period, and the reported amounts of revenues and expenses during each fiscal period. We continually evaluate these judgments and estimates based on our own historical experience, knowledge and assessment of current business and other conditions, our expectations regarding the future based on available information and assumptions that we believe to be reasonable.
13
The selection of critical accounting policies, the judgments and other uncertainties affecting the application of those policies and the sensitivity of reported results to changes in conditions and assumptions are factors that should be considered when reviewing our financial statements. We believe the following accounting policies involve the most significant judgments and estimates used in the preparation of our consolidated financial statements.
Fair value of financial instruments
Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.
Authoritative literature provides a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. We follow ASC subtopic 820-10, Fair Value Measurements and Disclosures, which establishes a three-tier fair value hierarchy, and prioritizes the inputs used in measuring fair value as follows:
| ● | Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. |
| ● | Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted market prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. |
| ● | Level 3 - inputs to the valuation methodology are unobservable. |
ASC 820 describes three main approaches to measuring the fair value of assets and liabilities: (1) market approach; (2) income approach and (3) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset.
Unless otherwise disclosed, the fair value of our financial instruments including cash and cash equivalents, accounts receivable, bank acceptance notes, other receivables, short-term loans, accounts payable, other payables, and amounts due to related parties approximate their recorded values due to their short-term maturities. The fair value of longer-term leases approximates their recorded values as their stated interest rates approximate the rates currently available.
Our non-financial assets, such as property and equipment and intangible assets would be measured at fair value only if they were determined to be impaired. When there is impairment of equity investments accounted for under the measurement alternative, the non-recurring fair value measurements are measured at the date of impairment. Estimating the fair value of the equity investment without observable market prices is highly judgmental due to the subjectivity of the unobservable inputs (level 3) used in the valuation methodologies used to determine fair value.
Leases
We account for leases following FASB ASC 842, Leases (“Topic 842”). We lease properties from property owners. In evaluating whether an agreement constitutes a lease. We review the contractual terms to determine which party obtains both the economic benefits and control of the assets at the inception of the contract. We categorize leases with contractual terms longer than twelve months as either operating or finance lease at the commencement date of a lease.
14
We recognize a lease liability for future fixed lease payments and a right-of-use (“ROU”) asset representing the right to use the underlying asset for the lease term. The lease term is based on the non-cancellable term of the lease and may contain options to extend the lease when it is reasonably certain that we will exercise the option. Lease liabilities are recognized at commencement date based on the present value of fixed lease payments over the lease term using the rate implicit in the lease, if available, or our incremental borrowing rate. As its leases do not provide an implicit borrowing rate, we use an incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at the commencement date. Current maturities of operating lease liabilities are classified as operating lease liabilities, current in our unaudited consolidated balance sheets. Most leases have initial terms ranging from 1 to 3 years. Besides, our lease payments are fixed. Lease expense for fixed lease payments is recognized on a straight-line basis over the lease term. Our lease agreements do not contain any significant residual value guarantees or restricted covenants. The ROU assets are measured at the amount of the lease liabilities with adjustments, if applicable, for lease prepayments made prior to or at lease commencement, initial direct costs incurred by us, deferred rent and lease incentives. We evaluate the carrying value of ROU assets if there are indicators of impairment and review the recoverability of the related asset group.
We reassess of a contract is or contains a leasing arrangement and re-measures ROU assets and liabilities upon modification of the contract. We will derecognize ROU assets and liabilities, with a difference recognized in the income statement on the contract termination.
Operating leases are included in operating lease right-of-use (“ROU”) assets, current portion of lease liabilities, and non-current portion of lease liabilities, on our unaudited consolidated balance sheets.
Revenue recognition
We account for revenue recognition under FASB ASC 606, Revenue from Contracts with Customers (“ASC 606”). In accordance with FASB ASC 606, Revenue from Contracts with Customers, we recognized revenue to represent the transfer of products or services to customers in an amount that reflects the consideration to which we expect to be entitled in such exchange. This will require us to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of the product or the benefit of the services transfers to the customer. Under the guidance of ASC 606, we are required to (a) identify the contract with a customer, (b) identify the performance obligations in the contract, (c) determine the transaction price, (d) allocate the transaction price to the performance obligations in the contract and (e) recognize revenue when (or as) we satisfy our performance obligations.
Our main business income is divided into three categories, one is mold production, that is, contracts are signed to sell molds widely used in automobiles, valves, water pumps and other industries according to the customer’s needs. Second is mold repair, which provides customers with mold repair service, or provides sales of mold components. Last is providing customers with machining services, using our remaining capacity to provide customers with external processing services. Revenues represent the amount of consideration that we are entitled to in exchange for the transfer of promised goods or services in the ordinary course of our activities and is recorded net of value-added tax (“VAT”). Consistent with the criteria of ASC 606, we recognize revenue when the performance obligation in a contract is satisfied by transferring the control of promised goods or services to the customer. We elect to account for shipping and handling activities as a fulfillment cost rather than as a separate performance obligation, of which was expensed as incurred and amounted to $58,850 and $37,430 for the six months ended June 30, 2026 and 2025, respectively.
Mold Production:
We sign contracts with customers and provide products according to the sales contract or sales list. The clients check the quantity and quality of products received and then issue confirmation as proof of payment. Certain clients may also test the finished products as part of the confirmation process. Revenue is recognized when we receive the confirmation of product acceptance.
15
We provide design and production services according to the sales contract or lists. Then we transport the finished products when clients give their order.
The design services are inseparable from project sales. A mold production contract may include two or more machine components, but all components are customized according to customer requirements. These components need to be combined under the guidance of design plans to produce qualified products to meet the needs of clients. Therefore, these services are highly interdependent and are never transferred to the customer on their own. Customers do not have the option to purchase these services separately principally due to the customization of each project. Accordingly, these services are not considered separate performance obligations, and no revenue is associated with these services under FASB ASC 606 until the point in time when the project is complete and delivered, and client confirmation is received.
We provide maintenance services and according to the contracts the clients do not have the option to purchase these services separately. The promised warranty does not provide the clients with a service in addition to the assurance that the product complies with agreed-upon contract specifications and is considered an assurance warranty. The maintenance services and the warranty are not considered separate performance obligations, and no revenue is associated with these services under ASC 606. Historically, we have not experienced material costs for quality assurance and, therefore, do not believe an accrual for these costs is necessary.
Mold Repair:
We sign contracts with customers and provide repair services according to the contract or list and charge a certain fee. Revenue is recognized only after the repair service has passed the customer’s inspection.
Machining Services:
We sign contracts with customers and provide machining services and charge a certain fee. We identify the fulfillment of its obligation when transferring the product and getting confirmation from customers to issue the VAT invoice at which time revenue is recognized.
Contract Balances
We classify its right to consideration in exchange for services or products transferred to a customer as either a receivable or a contract asset. A receivable is a right to consideration that is unconditional as compared to a contract asset which is a right to consideration that is conditional upon factors other than the passage of time. We recognize accounts receivable in its consolidated balance sheets when it performs a service in advance of receiving consideration and it has the unconditional right to receive consideration. A contract asset is recorded when we have transferred services or products to the customer before payment is received or is due, and the right to consideration is conditional on future performance or other factors in the contract. As of June 30, 2026 and December 31, 2025, we had no contract assets.
We capitalized incremental costs incurred to fulfill contracts that (1) relate directly to the contract, (2) are expected to generate resources that will be used to satisfy the performance obligation under the contract, and (3) are expected to be recovered through revenue generated under the contract. The compensation expenses of workforce hired and depreciation of certain equipment and overheads for the purpose of providing certain machining services are considered incremental costs to fulfill the contracts. These contract costs are recorded as cost of revenues upon the recognition of the related revenues. Provisions for estimated losses, if any, on uncompleted contracts are recorded in the period in which such losses become probable based on the current contract estimates. As of June 30, 2026 and December 31, 2025, we had deferred contract costs of $90,722 and $49,763, respectively. Impairment for contract costs amounted to $7,465 and 13,165 for the six months ended June 30, 2026 and 2025, respectively
Contract liabilities are recognized if we receive consideration prior to satisfying the performance obligations, which are customer advances. The consideration received from customers related to the remaining arrangements are included in advance from customer balance.
16
As of June 30, 2026 and December 31, 2025, advance from customers amounted to $95,882 and $108,356, respectively. During the six months ended June 30, 2026 and 2025, the Company recognized revenue that were previously deferred as contract liabilities amounted to $91,629, and $501,285, respectively.
Current expected credit losses
On January 1, 2023, we adopted ASC 326, Financial Instruments-Credit Losses, which requires recognition of allowances upon origination or acquisition of financial assets at an estimate of expected credit losses over the contractual term of the financial assets (the current expected credit loss or the “CECL” model) using the modified retrospective transition method.
Our financial assets subject to the CECL model mainly include accounts receivable, bank acceptance notes and other receivables and deposits in other assets, non-current.
For accounts receivable and bank acceptance notes, we estimate the loss rate based on historical experience, the age of the receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. For other receivables and other assets, non-current, we review other receivables and other assets, non-current on a periodic basis and makes allowances on an individual basis when there is doubt as to the collectability. Receivables are written off after all collection efforts have been exhausted.
For the six months ended June 30, 2026 and 2025, allowance of credit losses made by the Company were mainly generated from accounts receivable.
Long-term investment
Our equity investments without readily determinable fair value are a long-term investment in an unlisted company. For equity securities without readily determinable fair value and do not qualify for the existing practical expedient in ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”) to estimate fair value using the net asset value per share (or its equivalent) of the investment, we elected to use the measurement alternative under ASC 321, Investments — Equity Securities (“ASC 321”) to measure those investments at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer, if any. These investments are measured at fair value on a nonrecurring basis when an orderly transaction for identical or similar investments of the same issuer was identified or when there are events or changes in circumstances that may have a significant adverse effect. The non-recurring fair value measurements to the carrying amount of an investment usually requires management to estimate a price adjustment for the different rights and obligations between a similar instrument of the same issuer with an observable price change in an orderly transaction and the investment held by us. The valuation methodologies involved require management to use the observable transaction price at the transaction date and other unobservable inputs (level 3).
We make a qualitative assessment of whether the equity investments are impaired at each reporting date. If a qualitative assessment indicates that the investment is impaired, we estimate the investment’s fair value in accordance with the principles of ASC 820. If the fair value is less than the investment’s carrying value, we recognize an impairment loss in the statements of operations and comprehensive income (loss) equal to the difference between the carrying value and fair value.
Income taxes
Mingteng International’s subsidiaries in the PRC and Hong Kong are subject to the income laws of the PRC and Hong Kong. No taxable income was generated outside the PRC for the six months ended June 30, 2026 and 2025. Current income taxes are provided on the basis of net (loss) income for financial reporting purposes and adjusted for income and expense items which are not assessable or deductible for income tax purposes, in accordance with the regulations of the relevant tax jurisdictions. Deferred income taxes are provided using the asset and liability method. Under this method, deferred income tax assets and liabilities are recognized for the tax effects of temporary differences and are determined by applying enacted statutory tax rates that will be in effect in the period in which the temporary differences are expected to reverse to the temporary differences between the financial statements’ carrying amounts and the tax bases of assets and liabilities. Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset deferred tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity.
17
A valuation allowance is provided to reduce the amount of deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred income tax assets will not be realized. The effect on deferred income taxes arising from a change in tax rates is recognized in the unaudited consolidated statements of comprehensive income (loss) in the period of change.
We apply a “more likely than not” recognition threshold in the evaluation of uncertain tax positions. We recognize the benefit of a tax position in its consolidated financial statements if the tax position is “more likely than not” to prevail based on the facts and technical merits of the position. Tax positions that meet the “more likely than not” recognition threshold are measured at the largest amount of tax benefit that has a greater than fifty percent likelihood of being realized upon settlement. Unrecognized tax benefits may be affected by changes in interpretation of laws, rulings of tax authorities, tax audits, and expiry of statutory limitations. In addition, changes in facts, circumstances and new information may require us to adjust the recognition and measurement estimates with regard to individual tax positions. Accordingly, unrecognized tax benefits are periodically reviewed and reassessed. Adjustments, if required, are recorded in our consolidated financial statements in the period in which the change that necessities the adjustments occur. The ultimate outcome for a particular tax position may not be determined with certainty prior to the conclusion of a tax audit and, in certain circumstances, a tax appeal or litigation process. We record interest and penalties related to unrecognized tax benefits (if any) in interest expenses and general and administrative expenses, respectively. As of June 30, 2026 and December 31, 2025, we did not have any significant unrecognized uncertain tax positions.
Recent accounting pronouncements
We are an “emerging growth company” (“EGC”) as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, EGC can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards.
Recent Accounting Pronouncements Adopted
In July 2025, the FASB issued ASU 2025-05, “Financial Instruments — Credit Losses (Topic 326)”. Measurement of Credit Losses for Accounts Receivables and Contract Assets, which provides all entities with practical expedient of developing reasonable and supportable forecasts as part of estimating excepted credit losses, that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted in both interim and annual reporting periods in which financial statements have not yet been issued or made available for issuance. We adopted this ASU on a prospective basis effective January 1, 2026, the adoption of this guidance did not have a material impact on our unaudited interim condensed consolidated financial statements and related disclosures.
18
Recent Accounting Pronouncements Issued but not yet Adopted
In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topics 740): Improvements to Income Tax Disclosures” ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. For public business entities, the amendments in this update are effective for annual periods beginning after December 15, 2024. For entities other than public business entities, the amendments are effective for annual periods beginning after December 15, 2025. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. We are currently evaluating the impact of adopting the standard and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations and cash flows.
In November 2024, the FASB issued ASU 2024-03, “Reporting Comprehensive Income — Expense Disaggregation Disclosures”, which focuses on improving the disclosures about a public business entity’s expenses and addresses requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, SG&A, and research and development). The amendments in this update should be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this update or (2) retrospectively to any or all prior periods presented in the financial statements. In January 2025, the FASB issued ASU 2025-01, “Income Statement — Reporting Comprehensive Income—Expense Disaggregation Disclosures”. The amendment in ASU 2025-01 amends the effective date of ASC 2024-03 to clarify that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating the impact of this amendment and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations and cash flows.
We do not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on our consolidated financial position, statements of operations and comprehensive income (loss) and cash flows.
19
As of June 30, 2026, no business combination has been completed and the related acquisition activities remain in progress. Accordingly, the balance continues to be presented as a deposit. The Company will reclassify the deposit as part of the consideration transferred upon execution of a definitive agreement and the transfer of the related rights and obligations.
As of the report issue date, the Company has completed the related acquisition, see Note 17 of the unaudited interim condensed consolidated financial statements.
On January 14, 2026, the Company paid a refundable prepayment of $4,500,000 for the investment to Hong Kong Sanyou Petroleum Co., Limited. As of June 30, 2026, no acquisition or investing activities have been completed and the related acquisition or investing activities remain in progress. Accordingly, the balance continues to be presented as a deposit. The Company will reclassify the deposit as part of the consideration transferred upon execution of a definitive agreement and the transfer of the related rights and obligations.
The payment represents a refundable investment advance, rather than non-refundable service fees, resource fees, or deposits, and does not necessarily constitute a completed investment in the counterparty or any candidate project.
Exhibit 99.2
INDEX TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Mingteng International Corporation Inc.
| Unaudited Interim Condensed Consolidated Financial Statements | ||
| Condensed Consolidated Balance Sheets as of June 30, 2026 (Unaudited) and December 31, 2025 | F-2 | |
| Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Loss for the Six Months Ended June 30, 2026 and 2025 | F-3 | |
| Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Six Months Ended June 30, 2026 and 2025 | F-4 | |
| Unaudited Interim Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2026 and 2025 | F-5 | |
| Notes to Unaudited Interim Condensed Consolidated Financial Statements | F-6 - F-29 |
F-1
MINGTENG INTERNATIONAL CORPORATION INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
| June 30, | December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Short-term investments | ||||||||
| Accounts receivable, net | ||||||||
| Other receivables-bank acceptance notes | ||||||||
| Advances to suppliers | ||||||||
| Other receivables | ||||||||
| Inventories, net | ||||||||
| Contract costs, net | ||||||||
| Total current assets | ||||||||
| Non-current Assets | ||||||||
| Property and equipment, net | ||||||||
| Intangible assets | ||||||||
| Operating lease right-of-use assets, net | ||||||||
| Other assets, non-current | ||||||||
| Total non-current assets | ||||||||
| Total Assets | $ | $ | ||||||
| LIABILITIES AND EQUITY | ||||||||
| Current Liabilities | ||||||||
| Short-term loans | $ | $ | ||||||
| Accounts payable | ||||||||
| Other payables and other current liabilities | ||||||||
| Income tax payable | ||||||||
| Advances from customers | ||||||||
| Amounts due to related parties | ||||||||
| Current portion of lease liabilities | ||||||||
| Total current liabilities | ||||||||
| Non-current Liabilities | ||||||||
| Deferred tax liabilities | ||||||||
| Non-current portion of lease liabilities | ||||||||
| Total non-current liabilities | ||||||||
| Total liabilities | ||||||||
| Commitments and contingencies | ||||||||
| Shareholders’ Equity: | ||||||||
| Class A Ordinary shares (Par value $ | ||||||||
| Class B Ordinary shares (Par value $ | ||||||||
| Additional paid-in capital | ||||||||
| Statutory reserves | ||||||||
| Accumulated deficits | ( | ) | ( | ) | ||||
| Accumulated other comprehensive income (loss) | ( | ) | ||||||
| Total shareholders’ equity | ||||||||
| Total Liabilities and Shareholders’ Equity | $ | $ | ||||||
| * |
The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.
F-2
MINGTENG INTERNATIONAL CORPORATION INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)
| For the Six Months Ended June 30, |
||||||||
| 2026 | 2025 | |||||||
| Revenues | $ | $ | ||||||
| Cost of revenues | ( | ) | ( | ) | ||||
| Gross profit | ||||||||
| Operating expenses: | ||||||||
| Selling expenses | ( | ) | ( | ) | ||||
| General and administrative expenses | ( | ) | ( | ) | ||||
| Research and development expenses | ( | ) | ( | ) | ||||
| Total operating expenses | ( | ) | ( | ) | ||||
| (Loss) income from operations | ( | ) | ||||||
| Other income (expenses): | ||||||||
| Government subsidies | ||||||||
| Interest income | ||||||||
| Interest expense | ( | ) | ( | ) | ||||
| Other-than-temporary impairment | - | ( | ) | |||||
| Other (expense) income, net | ( | ) | ||||||
| Total other income (expenses), net | ( | ) | ||||||
| Loss before income taxes | ( | ) | ( | ) | ||||
| Benefit from (Provision for) income taxes | ( | ) | ||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Comprehensive loss | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Foreign currency translation adjustment | ||||||||
| Total comprehensive loss | $ | ( | ) | $ | ( | ) | ||
| Loss per share | ||||||||
| - Basic and diluted loss per ordinary share | - | $ | ( | ) | ||||
| - Basic and diluted loss per Class A Ordinary Share * | $ | ( | ) | - | ||||
| Weighted average number of ordinary shares outstanding | ||||||||
| - Weighted average ordinary shares outstanding | ||||||||
| - Weighted average Class A Ordinary Shares outstanding * | - | |||||||
| * |
The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.
F-3
MINGTENG INTERNATIONAL CORPORATION INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(Unaudited)
| Ordinary shares* |
Additional paid-in |
Statutory | (Accumulated deficit) retained |
Accumulated other comprehensive |
Total | |||||||||||||||||||||||
| Shares | Amount | capital | reserves | earnings | loss | equity | ||||||||||||||||||||||
| Balance as of December 31, 2024 | $ | ( | ) | |||||||||||||||||||||||||
| Net loss | - | - | - | - | ( | ) | - | ( | ) | |||||||||||||||||||
| Foreign currency translation adjustment | - | - | - | - | - | |||||||||||||||||||||||
| Balance as of June 30, 2025 (unaudited) | $ | ( | ) | ( | ) | |||||||||||||||||||||||
| Class A Ordinary shares* |
Class B Ordinary shares* |
Additional paid-in |
Statutory | Accumulated | Accumulated other comprehensive |
Total | ||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | capital | reserves | deficit | (loss) income | equity | ||||||||||||||||||||||||||||
| Balance as of December 31, 2025 | $ | $ | ( | ) | ( | ) | ||||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | ( | ) | - | ( | ) | ||||||||||||||||||||||||||
| Foreign currency translation adjustment | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||
| Reduction of par value | - | ( | ) | - | ( | ) | - | - | - | - | ||||||||||||||||||||||||||
| Issuance of Class A Ordinary shares | - | - | - | - | - | |||||||||||||||||||||||||||||||
| Share-based compensation | - | - | - | - | - | |||||||||||||||||||||||||||||||
| Issuance of Class A Ordinary shares upon exercise of pre-funded warrants | - | - | ( | ) | - | - | - | - | ||||||||||||||||||||||||||||
| Balance as of June 30, 2026 (unaudited) | $ | $ | ( | ) | ||||||||||||||||||||||||||||||||
| * |
The accompanying notes are an integral part of these unaudited interim condensed consolidated financial Statements.
F-4
MINGTENG INTERNATIONAL CORPORATION INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| For the Six Months Ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation of property and equipment | ||||||||
| Amortization of intangible assets | ||||||||
| Amortization of right-of-use assets | ||||||||
| Gain on short-term investments | ( | ) | - | |||||
| Share-based compensation expenses | - | |||||||
| Impairment loss on long-term investments | - | |||||||
| Provision of credit losses | ||||||||
| Deferred income tax | ( | ) | ||||||
| Loss on disposal of property and equipment | - | |||||||
| Provision for inventory impairment | - | |||||||
| Provision for contract costs impairment | ||||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | ||||||||
| Other receivables-bank acceptance notes | ( | ) | ( | ) | ||||
| Advances to suppliers | ( | ) | ||||||
| Other receivables | ||||||||
| Inventories | ( | ) | ( | ) | ||||
| Contract costs | ( | ) | ||||||
| Accounts payable | ||||||||
| Advances from customers | ( | ) | ( | ) | ||||
| Payroll payable | ||||||||
| Taxes payable | ( | ) | ||||||
| Other payables | ||||||||
| Amounts due to related parties | ( | ) | ||||||
| Change in operating lease liabilities | ( | ) | ( | ) | ||||
| Net cash used in operating activities | ( | ) | ( | ) | ||||
| Cash flows from investing activities | ||||||||
| Purchase of property and equipment | ( | ) | ( | ) | ||||
| Purchases of intangible assets | ( | ) | - | |||||
| Prepayment for equity subscription | ( | ) | - | |||||
| Purchase short-term investments | ( | ) | - | |||||
| Maturities of short-term investments | - | |||||||
| Prepayment for acquisition related deposits | ( | ) | - | |||||
| Interest-free loan to third parties | ( | ) | - | |||||
| Repayment of interest-free loan to third parties | - | |||||||
| Net cash used in investing activities | ( | ) | ( | ) | ||||
| Cash flows from financing activities | ||||||||
| Proceeds from short-term loans | ||||||||
| Repayment of short-term loans | - | ( | ) | |||||
| Proceeds from third party loans | - | |||||||
| Repayments of third party loans | ( | ) | - | |||||
| Cash receipts from equity issuance, net of issuance cost | - | |||||||
| Net cash provided by financing activities | ||||||||
| Effect of foreign exchange rate change on cash and cash equivalents | ||||||||
| Net increase (decrease) in cash and cash equivalents | ( | ) | ||||||
| Cash and cash equivalents at the beginning of the period | ||||||||
| Cash and cash equivalents at the end of the period | $ | $ | ||||||
| Supplemental disclosures of cash flow information: | ||||||||
| Interest paid | $ | $ | ||||||
| Income taxes paid | $ | $ | ||||||
| Non-cash investing activities: | ||||||||
| Liabilities incurred for purchasing of property and equipment | ||||||||
The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.
F-5
MINGTENG INTERNATIONAL CORPORATION INC.
NOTES TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 - BUSINESS DESCRIPTION
Mingteng International Corporation Inc. (“Mingteng International” or the “Company”) is a holding company incorporated under the laws of the Cayman Islands on September 20, 2021. It is a holding company with no business operations.
On November 4, 2021, Mingteng International formed its wholly-owned subsidiary, Mingteng International Hong Kong Group Limited (“Mingteng HK”) in Hong Kong. On September 26, 2022, Mingteng HK formed its wholly-owned subsidiary, Wuxi Ningteng Intelligent Manufacturing Co., Ltd. (“Ningteng WFOE”) in the People’s Republic of China (“PRC”).
Wuxi Mingteng Mould Technology Co., Ltd. (“Wuxi Mingteng Mould”) is a limited liability company incorporated on December 15, 2015 under the laws of the PRC. Wuxi Mingteng Mould is a wholly owned subsidiary of Ningteng WFOE and is the Company’s operating entity. Wuxi Mingteng Mould is primarily engaged in providing clients with comprehensive and personalized mold services and solutions in the PRC, including mold design and development; mold production, repair, testing and adjustment.
On April 22, 2024, Mingteng International completed its initial public offering on the Nasdaq Stock Market, issuing
Mingteng International’s current corporate structure is as follows:
Mingteng International conducts all of its operations in China through its operating subsidiary, Wuxi Mingteng Mould.
F-6
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”). The interim results of operations are not necessarily indicative of results to be expected for any other interim period or for a full year. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, considered necessary for a fair presentation of its financial position and operating results have been included. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Mingteng International’s audited consolidated financial statements and the related notes thereto for the fiscal year ended December 31, 2025, included in Form 20-F filed on April 30, 2026.
Principles of consolidation
The unaudited consolidated financial statements include the financial statements of the Company and its subsidiaries. All transactions and balances between the Company and its subsidiaries have been eliminated upon consolidation.
A subsidiary is an entity in which the Company, directly or indirectly, controls more than one half of the voting power, has the power to appoint or remove the majority of the members of the board of directors, to cast a majority of votes at the meeting of the board of directors or to govern the financial and operating policies of the investee under a statute or agreement among the shareholders or equity holders.
Use of estimates
In preparing the unaudited consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the assessment of the allowance for credit losses, the allowance for inventory and contract costs provision, useful lives of property and equipment, the recoverability of long-lived assets and long-term investments, provision necessary for contingent liabilities. Actual results could differ from those estimates.
Cash and cash equivalents
Cash includes cash on hand and demand deposits in accounts maintained with commercial banks. The Company considers all highly liquid investments that are readily convertible to known amounts of cash and with original maturities from the date of purchase of three months or less to be cash equivalents. The Company maintains its bank accounts in Mainland China, Hong Kong and Cayman Islands. On May 1, 2015, China’s new Deposit Insurance Regulation became effective, pursuant to which banking financial institutions, such as commercial banks, established in the PRC are required to purchase deposit insurance for deposits in RMB and in foreign currency placed with them. The insurance limit is RMB
Accounts receivable, net
Accounts receivables are stated at the original amount less an allowance for credit loss. Accounts receivables are recognized in the period when the Company has provided services to its customers and when its right to consideration is unconditional. The Company reviews the accounts receivable on a periodic basis and makes general and specific allowances when there is doubt as to the collectability of individual balances. The Company has developed a current expected credit loss (“CECL”) model based on historical experience, the age of the accounts receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The Company considers historical collection rates, current financial status, macroeconomic factors, and other industry-specific factors when evaluating current expected credit losses. Accounts receivable balances are written off after all collection efforts have been exhausted.
F-7
Current expected credit losses
On January 1, 2023, the Company adopted ASC 326, Financial Instruments-Credit Losses, which requires recognition of allowances upon origination or acquisition of financial assets at an estimate of expected credit losses over the contractual term of the financial assets (the current expected credit loss or the “CECL” model) using the modified retrospective transition method.
The Company’s financial assets subject to the CECL model mainly include accounts receivable, bank acceptance notes and other receivables and deposits in other assets, non-current.
For accounts receivable and bank acceptance notes, the Company estimates the loss rate based on historical experience, the age of the receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. For other receivables and other assets, non-current, the Company reviews other receivables and other assets, non-current on a periodic basis and makes allowances on an individual basis when there is doubt as to the collectability. Receivables are written off after all collection efforts have been exhausted.
For the six months ended June 30, 2026 and 2025, allowance of credit losses made by the Company were mainly generated from accounts receivable.
Bank acceptance notes
Bank acceptance notes generally due within six months and with specific payment terms and definitive due dates, are comprised of the notes issued by some customers to pay certain outstanding receivable balances to the Company. Bank acceptance notes do not bear interest. From time to time, the Company endorses bank acceptance notes receivable to its suppliers as payment of material purchase. The bank acceptance notes receivable is considered sold and derecognized from balance sheets when they are transferred beyond the reach of the Company and its creditors, the purchaser has the right to pledge or exchange the note receivables, and the Company has surrendered control over the transferred note receivable. If the Company does not surrender control, the cash received from the purchaser is accounted for as a secured borrowing.
Advances to suppliers
Advances to suppliers consist of balances paid to suppliers for goods and services that have not been provided or received. The Company reviews its advances to suppliers on a periodic basis and makes general and specific allowances when there is doubt as to the ability of a supplier to provide goods or services to the Company or refund an advance. For the six months ended June 30, 2026 and 2025, there was no allowance of advances to suppliers.
Short-term investments
Short-term investments include the wealth management products, which are issued by commercial banks. For wealth management products with a variable interest rate indexed to the performance of underlying assets or principal not guaranteed, the Company elected the fair value method at the date of initial recognition and carried these investments subsequently at fair value. Fair value is estimated primarily based on quoted prices of similar financial products provided by commercial bank at the end of each period. Changes in the fair value are reflected in the consolidated statements of operations and comprehensive income as “Other income, net”.
Inventories, net
Inventories consist of raw materials, work in process and finished goods, and are stated at the lower of cost or net realizable value. Cost is determined using the weighted average method. The Company periodically evaluates its inventories and will record an allowance for inventories that are either slow-moving, may not be saleable or whose cost exceeds its net realizable value. For the six months ended June 30, 2026 and 2025 the Company made provision for inventory obsolescence of $
F-8
Property and equipment, net
Property and equipment are carried at cost and are depreciated on the straight-line basis over the estimated useful lives of the underlying assets. Repair and maintenance costs are charged to expense as incurred, whereas the cost of renewals and betterments that extend the useful life of fixed assets are capitalized as additions to the related assets. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in the value of its property and equipment, when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.
Estimated useful lives are as follows, taking into account the assets’ estimated residual value of 5%:
| Category | Estimated useful lives | |
| Electronic equipment | ||
| Vehicles | ||
| Machinery and equipment | ||
| Leasehold improvements | Over the shorter of lease term or the estimated useful lives of the assets |
Intangible assets
Intangible asset is software license, which are purchased from third parties and initially recorded at cost and amortized on a straight-line basis over the service term of
Impairment of long-lived assets
Long-lived assets of the Company are reviewed for impairment in accordance with ASC 360, “Property, Plant and Equipment” whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.
For the six months ended June 30, 2026 and 2025, no impairment charges were recognized.
Long-term investment
The Company’s equity investments without readily determinable fair value are a long-term investment in an unlisted company. For equity securities without readily determinable fair value and do not qualify for the existing practical expedient in ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”) to estimate fair value using the net asset value per share (or its equivalent) of the investment, the Company elected to use the measurement alternative under ASC 321, Investments — Equity Securities (“ASC 321”) to measure those investments at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer, if any. These investments are measured at fair value on a nonrecurring basis when an orderly transaction for identical or similar investments of the same issuer was identified or when there are events or changes in circumstances that may have a significant adverse effect. The non-recurring fair value measurements to the carrying amount of an investment usually requires management to estimate a price adjustment for the different rights and obligations between a similar instrument of the same issuer with an observable price change in an orderly transaction and the investment held by the Company. The valuation methodologies involved require management to use the observable transaction price at the transaction date and other unobservable inputs (level 3).
F-9
The Company makes a qualitative assessment of whether the equity investments are impaired at each reporting date. If a qualitative assessment indicates that the investment is impaired, the Company estimates the investment’s fair value in accordance with the principles of ASC 820. If the fair value is less than the investment’s carrying value, the Company recognizes an impairment loss in the statements of operations and comprehensive income (loss) equal to the difference between the carrying value and fair value.
The Company’s long-term investment balance was nil as of both June 30, 2026 and December 31, 2025, due to an impairment of the long-term investment recorded as of December 31, 2025. For the six months ended June 30, 2026 and 2025, impairment losses of long-term investment were nil and $
Fair value of financial instruments
Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.
Authoritative literature provides a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company follows ASC subtopic 820-10, Fair Value Measurements and Disclosures, which establishes a three-tier fair value hierarchy, and prioritizes the inputs used in measuring fair value as follows:
| ● | Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. |
| ● | Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted market prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. |
| ● | Level 3 - inputs to the valuation methodology are unobservable. |
ASC 820 describes three main approaches to measuring the fair value of assets and liabilities: (1) market approach; (2) income approach and (3) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset.
Unless otherwise disclosed, the fair value of the Company’s financial instruments including cash and cash equivalents, accounts receivable, bank acceptance notes, other receivables, short-term loans, accounts payable, other payables, and amounts due to related parties approximate their recorded values due to their short-term maturities. The fair value of longer-term leases approximates their recorded values as their stated interest rates approximate the rates currently available.
The Company’s non-financial assets, such as property, plant and equipment and intangible assets would be measured at fair value only if they were determined to be impaired. When there is impairment of equity investments accounted for under the measurement alternative, the non-recurring fair value measurements are measured at the date of impairment. Estimating the fair value of the equity investment without observable market prices is highly judgmental due to the subjectivity of the unobservable inputs (level 3) used in the valuation methodologies used to determine fair value.
Leases
The Company accounts for leases following FASB ASC 842, Leases (“Topic 842”). The Company leases properties from property owners. In evaluating whether an agreement constitutes a lease. The Company reviews the contractual terms to determine which party obtains both the economic benefits and control of the assets at the inception of the contract. The Company categorizes leases with contractual terms longer than twelve months as either operating or finance lease at the commencement date of a lease.
F-10
The Company recognizes a lease liability for future fixed lease payments and a right-of-use (“ROU”) asset representing the right to use the underlying asset for the lease term. The lease term is based on the non-cancellable term of the lease and may contain options to extend the lease when it is reasonably certain that the Company will exercise the option. Lease liabilities are recognized at commencement date based on the present value of fixed lease payments over the lease term using the rate implicit in the lease, if available, or the Company’s incremental borrowing rate. As its leases do not provide an implicit borrowing rate, the Company uses an incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at the commencement date. Current maturities of operating lease liabilities are classified as operating lease liabilities, current in the Company’s consolidated balance sheets. Most leases have initial terms ranging from
The Company reassesses whether a contract is or contains a lease arrangement and re-measures ROU assets and liabilities upon modification of the contract. The Company will derecognize ROU assets and liabilities, with a difference recognized in the income statement on the contract termination.
Operating leases are included in operating lease right-of-use (“ROU”) assets, current portion of lease liabilities, and non-current portion of lease liabilities, on the Company’s consolidated balance sheets.
Revenue recognition
The Company accounts for revenue recognition under FASB ASC 606, Revenue from Contracts with Customers (“ASC 606”). In accordance with ASC 606, Revenue from Contracts with Customers, the Company recognizes revenue to represent the transfer of products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of the product or the benefit of the services transfers to the customer. Under the guidance of ASC 606, the Company is required to (a) identify the contract with a customer, (b) identify the performance obligations in the contract, (c) determine the transaction price, (d) allocate the transaction price to the performance obligations in the contract and (e) recognize revenue when (or as) the Company satisfies its performance obligations.
The Company’s main business income is divided into three categories, one is mold production, that is, contracts are signed to sell molds widely used in automobiles, valves, water pump and other industries according to the customer’s needs. Second is mold repair, which provides customers with mold repair service, or provides sales of mold components. Last is providing customers with machining services, using the Company’s remaining capacity to provide customers with external processing services. Revenues represent the amount of consideration that the Company is entitled to in exchange for the transfer of promised goods or services in the ordinary course of the Company’s activities and is recorded net of value-added tax (“VAT”). Consistent with the criteria of ASC 606, the Company recognizes revenue when the performance obligation in a contract is satisfied by transferring the control of promised goods or services to the customer. The company elect to account for shipping and handling activities as a fulfillment cost rather than as a separate performance obligation, of which was expensed as incurred and amounted to $
Mold production:
The Company signs contracts with customers and provides products according to the sales contract or sales list. The clients check the quantity and quality of products received and then issue confirmation as proof of payment. Certain clients may also test the finished products as part of the confirmation process. Revenue is recognized when the Company receives the confirmation of product acceptance.
F-11
The Company provides design and production services according to the sales contract or lists. The Company then transports and installs the finished products when clients give their order.
The design services are inseparable from project sales. A mold production contract may include two or more machine components, but all components are customized according to customer requirements. These components need to be combined under the guidance of design plans to produce qualified products to meet the needs of clients. Therefore, these services are highly interdependent and are never transferred to the customer on their own. Customers do not have the option to purchase these services separately principally due to the customization of each project. Accordingly, these services are not considered separate performance obligations, and no revenue is associated with these services under ASC 606 until the point in time when the project is completed and delivered, and client confirmation is received.
The Company provides maintenance services and according to the contracts the clients do not have the option to purchase these services separately. The promised warranty does not provide the clients with a service in addition to the assurance that the product complies with agreed-upon contract specifications and is considered an assurance warranty. The maintenance services and the warranty are not considered separate performance obligations, and no revenue is associated with these services under ASC 606. Historically, the Company has not experienced material costs for quality assurance and, therefore, does not believe an accrual for these costs is necessary.
Mold repair:
The Company signs contracts with customers and provides repair services according to the contract or list and charges a certain fee. Revenue is recognized only after the repair service has passed the customer’s inspection.
Machining services:
The Company signs contracts with customers and provides machining services, supplies raw materials, and charges a certain fee. The Company identifies the fulfillment of its obligation when transferring the product and getting confirmation from customers to issue the VAT invoice at which time revenue is recognized.
The following table presents revenues by major revenue type for the six months ended June 30, 2026 and 2025, respectively:
| For the six months ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Mold production | $ | $ | ||||||
| Mold repair | ||||||||
| Machining services | ||||||||
| Total | $ | $ | ||||||
Contract Balances
The Company classifies its right to consideration in exchange for services or products transferred to a customer as either a receivable or a contract asset. A receivable is a right to consideration that is unconditional as compared to a contract asset which is a right to consideration that is conditional upon factors other than the passage of time. The Company recognizes accounts receivable in its consolidated balance sheets when it performs a service in advance of receiving consideration and it has the unconditional right to receive consideration. A contract asset is recorded when the Company has transferred services or products to the customer before payment is received or is due, and the right to consideration is conditional on future performance or other factors in the contract. As of June 30, 2026 and December 31, 2025, the Company had no contract assets.
F-12
The Company capitalizes incremental costs incurred to fulfill contracts that (1) relate directly to the contract, (2) are expected to generate resources that will be used to satisfy the performance obligation under the contract, and (3) are expected to be recovered through revenue generated under the contract. The compensation expenses of the workforce hired and depreciation of certain equipment and overheads for the purpose of providing certain machining services are considered incremental costs to fulfill the contracts. These contract costs are recorded as cost of revenues upon the recognition of the related revenues. Provisions for estimated losses, if any, on uncompleted contracts are recorded in the period in which such losses become probable based on the current contract estimates. As of June 30, 2026 and December 31, 2025, the Company had deferred contract costs of $
Contract liabilities are recognized if the Company receives consideration prior to satisfying the performance obligations, which are customer advances. The consideration received from customers related to the remaining arrangements are included in advance from customer balance.
As of June 30, 2026 and December 31, 2025, advance from customers amounted to $
Cost of revenues
Cost of revenues consists of the cost of raw material, direct labor and manufacturing costs. During the production process, the production department records the material consumption quantity and production hours of each order. Raw material cost is allocated according to the consumption of the material. Direct labor and manufacturing costs are allocated according to the production hours.
Selling expenses
Selling expenses primarily consist of (i) marketing promotion expenses to attract or retain consumers and increase company’s visibility, and labor costs and expenses for the salesman; and(ii) traveling expenses for the staffs.
General and administrative expenses
General and administrative expenses consist primarily of costs of salary, welfare and share-based payment for the Company general administrative and management staff, consulting fee, depreciation expenses, professional fees, meals and entertainment, office expenses, business travel expenses, additional expenses for public offering, and other miscellaneous expenses incurred in connection with general operations.
Research and development expenses
Research and development (“R&D”) expenses consist primarily of costs directly attributable to the conduct of R&D projects, including salaries, raw materials and outsourced R&D costs for projects entrusted to third-party companies. Such projects include the research and development of adjustable casting molds for automotive parts. All costs associated with research and development are expensed as incurred.
Government subsidies
Government subsidies refer to the monetary assets that a company obtains from the government for free. The government subsidies received by Wuxi Mingteng Mould mainly include high-tech enterprise recognition bonuses. The Company believes that these government subsidies are not related to daily business activities and are treated as other income.
Government subsidies for the six months ended June 30, 2026 and 2025, were $
F-13
Income taxes
Mingteng International’s subsidiaries in the PRC and Hong Kong are subject to the income laws of the PRC and Hong Kong. No taxable income was generated outside the PRC for the six months ended June 30, 2026 and 2025. Current income taxes are provided on the basis of net loss for financial reporting purposes and adjusted for income and expense items which are not assessable or deductible for income tax purposes, in accordance with the regulations of the relevant tax jurisdictions. Deferred income taxes are provided using the asset and liability method. Under this method, deferred income tax assets and liabilities are recognized for the tax effects of temporary differences and are determined by applying enacted statutory tax rates that will be in effect in the period in which the temporary differences are expected to reverse to the temporary differences between the financial statements’ carrying amounts and the tax bases of assets and liabilities. Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset deferred tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity.
A valuation allowance is provided to reduce the amount of deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred income tax assets will not be realized. The effect on deferred income taxes arising from a change in tax rates is recognized in the consolidated statements of comprehensive loss in the period of change.
The Company applies a “more likely than not” recognition threshold in the evaluation of uncertain tax positions. The Company recognizes the benefit of a tax position in its consolidated financial statements if the tax position is “more likely than not” to prevail based on the facts and technical merits of the position. Tax positions that meet the “more likely than not” recognition threshold are measured at the largest amount of tax benefit that has a greater than
Value added tax
Sales revenue represents the invoiced value of goods, net of VAT. The VAT is based on gross sales price and the VAT rate is
Losses per share
Mingteng International computes losses per share (“EPS”) in accordance with ASC 260, “Earnings per Share” (“ASC 260”). ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is computed by dividing the losses available to ordinary shareholders of Mingteng International by the weighted average ordinary shares outstanding during the period. Class B shares were excluded from the calculation of earnings per share because they do not possess any economic interests. Diluted net losses per share is computed using the weighted average number of ordinary shares and potential ordinary shares outstanding during the period under the treasury stock method. Potential ordinary shares include warrants, unless they were anti-dilutive. The computation of diluted net losses per share does not assume conversion, exercise, or contingent issuance of securities that would have an anti-dilutive effect (i.e. a decrease in loss per share amounts or an increase in earnings per share amounts) on net losses per share.
F-14
Warrants
The accounting treatment of warrants issued is determined pursuant to the guidance provided by ASC 470, Debt (“ASC 470”), ASC 480, Distinguishing Liabilities from Equity (“ASC 480”), and ASC 815, Derivatives and Hedging (“ASC 815”), as applicable. Each feature of freestanding financial instruments including, without limitation, any rights relating to subsequent dilutive issuances, equity sales, rights offerings, conversions, optional redemptions and dividends are assessed with determinations made regarding the proper classification in the Company’s consolidated financial statements. The Company evaluates whether such instruments are indexed to its own stock and whether they meet the conditions for equity classification, including the absence of mandatory cash settlement requirements outside the Company’s control.
Share-based compensation
Share based awards granted to employees are accounted for under ASC 718, “Compensation—Stock Compensation”, which requires that such equity awards granted to employees be measured based on the grant date fair value and recognized as compensation expense immediately at grant date if no vesting conditions are required.
Comprehensive loss
Comprehensive loss consists of two components, net loss and other comprehensive loss. Other comprehensive loss refers to revenue, expenses, gains, and losses that under U.S. GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive loss consists of foreign currency translation adjustments from the Company’s PRC subsidiaries not using U.S. dollar as its functional currency.
Foreign currency translation
The functional currency of Mingteng International’s operations in the PRC is the Chinese Yuan or Renminbi (“RMB”). The consolidated financial statements are translated to U.S. dollars using the period end rates of exchange for assets and liabilities, equity is translated at historical exchange rates, and average rates of exchange (for the period) are used for revenues and expenses and cash flows. As a result, amounts relating to assets and liabilities reported on the statements of cash flows may not necessarily agree with the changes in the corresponding balances on the balance sheets. Translation adjustments resulting from the process of translating the local currency financial statements into U.S. dollars are included in determining comprehensive income/loss. Transactions denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing on the transaction dates. Assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the results of operations as incurred.
All of the Company’s revenue transactions are transacted in its functional currency. The Company does not enter into any material transaction in foreign currencies. Transaction gains or losses have not had, and are not expected to have, a material effect on the results of the operations of the Company.
The following table outlines the currency exchange rates that were used in preparing the consolidated financial statements, representing exchange rate of the People’s Bank of China (PBOC):
| June 30, | December 31, | Six months ended June 30, | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Foreign currency | ||||||||||||||||
| RMB:1USD | ||||||||||||||||
Statement of cash flows
In accordance with ASC 230, Statement of Cash Flows, cash flows from the Company’s operations are formulated based upon the local currencies, and then translated at average translation rates for the periods. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.
F-15
Significant risks
Currency risk
A majority of the Company’s expense transactions are denominated in RMB and a significant portion of Mingteng International and its subsidiaries’ assets and liabilities are denominated in RMB. RMB is not freely convertible into foreign currencies. In the PRC, certain foreign exchange transactions are required by law to be transacted only by authorized financial institutions at exchange rates set by the People’s Bank of China (“PBOC”). Remittances in currencies other than RMB by the Company in China must be processed through the PBOC or other Company foreign exchange regulatory bodies which require certain supporting documentation in order to affect the remittance.
The Company maintains certain bank accounts in the PRC. On May 1, 2015, China’s new Deposit Insurance Regulation came into effect, pursuant to which banking financial institutions, such as commercial banks, established in the PRC are required to purchase deposit insurance for deposits in RMB and in foreign currency placed with them. Such Deposit Insurance Regulation would not be effective in providing complete protection for the Company’s accounts, as its aggregate deposits are much higher than the compensation limit, which is RMB
The Company also maintains certain bank deposits in Hong Kong, which are covered by the Hong Kong Deposit Protection Scheme, subject to the applicable eligibility requirements and coverage limits. The maximum protection limit is HK$
The total bank deposit balance was $
The functional currency and the reporting currency of the Company is USD, while the functional currency of the Company’s PRC subsidiaries is RMB. Since July 21, 2005, RMB has been permitted by the PRC government to fluctuate within a managed band against a basket of certain foreign currencies. The depreciation of the USD against the RMB was
Concentration and credit risk
Currently, all the Company’s operations are carried out in the PRC. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic, and legal environment in the PRC, and by the general state of the PRC’s economy. The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.
Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, accounts receivable, other receivables-bank acceptance notes. A portion of the Company’s sales are credit sales which are to the customers whose ability to pay is dependent upon the industry economics prevailing in these areas; however, concentrations of credit risk with respect to trade accounts receivables is limited due to generally short payment terms. The Company conducts credit evaluations of its customers and generally does not require collateral or other security from such customers. The Company periodically evaluates the creditworthiness of the existing customers in determining an allowance for credit losses primarily based upon the age of the receivables and factors surrounding the credit risk of specific customers.
F-16
Interest rate risk
Fluctuations in market interest rates may negatively affect the Company’s financial condition and results of operations. The Company is exposed to floating interest rate risk on cash deposit and the risks due to changes in interest rates are not material. The Company has not used any derivative financial instruments to manage the Company interest rate risk exposure.
Other uncertainty risk
The Company’s major operations are conducted in the PRC. Accordingly, the political, economic, and legal environments in the PRC, as well as the general state of the PRC’s economy may influence the Company’s business, financial condition, and results of operations.
Employee benefits
Pursuant to the relevant laws and regulations of the PRC, the Company’s subsidiaries in mainland China participate in a defined contribution of basic pension insurance in the social insurance system established and managed by government organizations. The Company makes contributions to basic pension insurance plans based on the applicable benchmarks and rates stipulated by the government. Basic pension insurance contributions are charged to costs of revenues and operating expenses as the related services are rendered by the employees. Employee social benefits included as costs of revenues and operating expenses were $
Recent accounting pronouncements
The Company is an “emerging growth company” (“EGC”) as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, EGC can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards.
Recent Accounting Pronouncements Adopted
In July 2025, the FASB issued ASU 2025-05, “Financial Instruments — Credit Losses (Topic 326)”. Measurement of Credit Losses for Accounts Receivables and Contract Assets, which provides all entities with practical expedient of developing reasonable and supportable forecasts as part of estimating excepted credit losses, that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted in both interim and annual reporting periods in which financial statements have not yet been issued or made available for issuance. The Company adopted this ASU on a prospective basis effective January 1, 2026 and did not elect the practical expedient permitted under this ASU. Therefore, the adoption has no material impact on our unaudited consolidated financial.
Recent Accounting Pronouncements Issued but not yet Adopted
In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topics 740): Improvements to Income Tax Disclosures” ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. For public business entities, the amendments in this update are effective for annual periods beginning after December 15, 2024. For entities other than public business entities, the amendments are effective for annual periods beginning after December 15, 2025. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact of adopting the standard and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations and cash flows.
F-17
In November 2024, the FASB issued ASU 2024-03, “Reporting Comprehensive Income — Expense Disaggregation Disclosures”, which focuses on improving the disclosures about a public business entity’s expenses and addresses requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, SG&A, and research and development). The amendments in this update should be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this update or (2) retrospectively to any or all prior periods presented in the financial statements. In January 2025, the FASB issued ASU 2025-01, “Income Statement — Reporting Comprehensive Income—Expense Disaggregation Disclosures”. The amendment in ASU 2025-01 amends the effective date of ASC 2024-03 to clarify that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this amendment and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations and cash flows.
The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s unaudited consolidated financial position, statements of operations and comprehensive (loss) income and cash flows.
NOTE 3 - ACCOUNTS RECEIVABLE
Accounts receivable consisted of the following:
| As of June 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Trade accounts receivable | $ | $ | ||||||
| Less: allowance for credit losses | ( | ) | ( | ) | ||||
| Accounts receivable, net | $ | $ | ||||||
The movements of allowance of credit losses were as follows:
| For the Six Months Ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Balance at the beginning of the period | $ | ( | ) | $ | ( | ) | ||
| Provision during the six months period | ( | ) | ( | ) | ||||
| Foreign exchange difference | ( | ) | ( | ) | ||||
| Balance at the end of the period | $ | ( | ) | $ | ( | ) | ||
F-18
NOTE 4 - INVENTORIES
Inventories consisted of the following:
| As of June 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Raw material | $ | $ | ||||||
| Work in process | ||||||||
| Goods in transit | ||||||||
| Inventories provision | ( | ) | ( | ) | ||||
| Total inventories | $ | $ | ||||||
The movements of provision for inventory were as follows:
| For the Six Months Ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Balance at the beginning of the period | $ | ( | ) | $ | ( | ) | ||
| Provision during the six months period | ( | ) | - | |||||
| Foreign exchange difference | ( | ) | ( | ) | ||||
| Balance at the end of the period | $ | ( | ) | $ | ( | ) | ||
The goods in transit to customers are still included in the inventory until the customer inspected and confirmed acceptance. Once obtaining the customer’s acceptance notice, the balance of goods in transit will be recognized in cost of revenues.
NOTE 5 - PROPERTY AND EQUIPMENT, NET
Property and equipment, stated at cost less accumulated depreciation, consisted of the following:
| As of June 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Mechanical equipment | $ | $ | ||||||
| Leasehold improvements | ||||||||
| Electronic equipment | ||||||||
| Vehicles | ||||||||
| Subtotal | ||||||||
| Less: accumulated depreciation | ( | ) | ( | ) | ||||
| Property and equipment, net | $ | $ | ||||||
For the six months ended June 30, 2026 and 2025, depreciation expenses amounted to $
F-19
NOTE 6 – OTHER RECEIVABLES
Other receivables consisted of the following:
| As of June 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Loans to third parties (1) | - | |||||||
| Others | ||||||||
| Total other assets, non-current | $ | $ | ||||||
| (1) |
On February 1, 2026, the Company entered into an unsecured, interest-free, revolving loan facility agreement with an unrelated third party, which provides for a maximum outstanding principal amount of $
NOTE 7 – ADVANCES TO SUPPLIERS
| As of June 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Advances for materials and services (1) | ||||||||
| Others | ||||||||
| Total other assets, non-current | $ | $ | ||||||
| (1) |
NOTE 8 – OTHER ASSETS, NON-CURRENT
Other assets, non-current consisted of the following:
| As of June 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Prepayment for acquisition related deposit (1) | $ | $ | ||||||
| Prepayment for equity subscription (2) | - | |||||||
| Deposit for lease | ||||||||
| Prepayment for the construction and equipment | ||||||||
| Total other assets, non-current | $ | $ | ||||||
| (1) | In 2025, the Company entered into an investment service agreement with a third-party consulting firm to source, evaluate, and manage potential investment opportunities on the Company’s behalf. In accordance with the agreement, the Company is required to place a refundable deposit with the consulting firm in connection with prospective acquisition transactions. During the year ended December 31, 2025, the Company remitted a deposit of $ |
As of June 30, 2026, no business combination has been completed and the related acquisition activities remain in progress. Accordingly, the balance continues to be presented as a deposit. The Company will reclassify the deposit as part of the consideration transferred upon execution of a definitive agreement and the transfer of the related rights and obligations.
F-20
As of the report issue date, the Company has completed the related acquisition, see Note 17 of the unaudited interim condensed consolidated financial statements.
On January 14, 2026, the Company paid a refundable prepayment of $
The payment represents a refundable investment advance, rather than non-refundable service fees, resource fees, or deposits, and does not necessarily constitute a completed investment in the counterparty or any candidate project.
| (2) |
NOTE 9 - LEASES
Operating lease expenses, which excluded short-term lease expenses, were $
Amounts recognized in the consolidated balance sheets are as follows:
| As of June 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Operating lease right-of-use assets | $ | $ | ||||||
| Operating lease liabilities, current | ||||||||
| Operating lease liabilities, non-current | ||||||||
| Total operating lease liabilities | $ | $ | ||||||
F-21
The weighted-average remaining lease term and the weighted-average discount rate of leases are as follows:
| June 30, 2026 | December 31, 2025 | |||||||
| Weighted-average remaining operating lease term | ||||||||
| Weighted-average operating discount rate | % | % | ||||||
The following table summarizes the maturity of lease liabilities as of June 30, 2026:
| 12 months ending June 30, | Amount | |||
| 2027 | $ | |||
| 2028 | ||||
| 2029 | ||||
| Total lease payments | ||||
| Less: imputed interest | ( | ) | ||
| Total lease liabilities | $ | |||
NOTE 10 - SHORT-TERM LOANS
As of June 30, 2026 and December 31, 2025, the loans were for working capital and capital expenditures. Loans consisted of the following:
| Creditor | Interest rate | Issuance Date | Maturity date | As of June 30, 2026 | As of December 31, 2025 | |||||||||||
| Wuxi Branch of Bank of China | % | |||||||||||||||
| China Merchants Bank Wuxi Xihui Branch | % | - | ||||||||||||||
| CITIC Bank Wuxi Huishan Branch | % | - | ||||||||||||||
| Total | $ | $ | ||||||||||||||
NOTE 11 - OTHER PAYABLES AND OTHER CURRENT LIABILITIES
Other payables and other current liabilities consisted of the following:
| As of June 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Other taxes payable(1) | $ | $ | ||||||
| Payroll payable | ||||||||
| Loans from third parties(2) | ||||||||
| Accrued expenses | ||||||||
| Total other liabilities | $ | $ | ||||||
| (1) |
| (2) |
F-22
On February 25, 2025, the Company borrowed an interest-free loan from a third party amounted to $
NOTE 12 - RELATED PARTY TRANSACTIONS
The table below sets the major related parties and their relationships with the Company:
| Name of related parties | Relationship with the Company | |
| Yingkai Xu | ||
| Jingzhu Ding | ||
| Wuxi Kaiteng Mold Factory |
Significant transactions with related parties were as follows:
| For the Six Months Ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Purchase from related parties: | ||||||||
| Wuxi Kaiteng Mold Factory(1) | $ | $ | ||||||
| Subtotal | $ | $ | ||||||
| (1) |
The following represented related party balances as of June 30, 2026 and December 31, 2025:
| As of June 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Amounts due to related parties | ||||||||
| Wuxi Kaiteng Mold Factory | $ | $ | ||||||
| Subtotal | $ | $ | ||||||
Amounts due to Wuxi Kaiteng Mold Factory represent amounts provided for processing services that the Company purchased from Wuxi Kaiteng Mold Factory.
F-23
NOTE 13 - SHAREHOLDERS’ EQUITY
(a) Reverse share split
The Company effected reverse share splits of its ordinary shares at ratios of 1-for-200 on January 26, 2026 (“2026 Reverse Share Split”). Share numbers and per-share data presented in this unaudited consolidated financial statements and related notes have been retroactively adjusted to reflect the cumulative effect of these reverse share splits.
As a result of the Reverse Stock Split, the par value of the Class A Ordinary shares and Class B Ordinary shares was increased to $
(b) Ordinary shares
On December 4, 2025, the Company entered into a Sales Agreement with AC Sunshine Securities LLC pursuant to which the Company may offer and sell from time to time Class A Ordinary Shares having an aggregate offering of up to $
On April 13, 2026, the Company entered into securities purchase agreements with certain investors, including Mr. Yingkai Xu, the Company’s Chief Executive Officer, relating to the issuance and sale of an aggregate of
The purchase price was below the market price on the issuance date. Such discount which represents the difference between the share price on the issuance date and the issuance price, represents a share-based compensation to Mr. Yingkai Xu for past services incurred in accordance with ASC 718, Compensation-Stock Compensation. Since the equity incentive plan agreement does not impose any vesting conditions or restrictions related to employee termination, the total compensation cost associated with the equity awards amount to $
On May 29, 2026, the Annual General Meeting of Shareholders (the “AGM”) approved: (i) the reduction of the par value per share from $
On June 9, 2026, the Company entered into a securities purchase agreement with certain individual investors, pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “2026 Direct Registered Offering”): (i)
F-24
On June 17, 2026, the Company entered into a securities purchase agreement with certain individual investors, pursuant to which the Company agreed to issue and sell in a registered direct offering: (i)
In a concurrent private placement, the Company also agreed to issue and sell to the same investors unregistered warrants to purchase up to an aggregate of
On June 17, 2026, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with FT Global Capital, Inc. (“FT Global” or the “Placement Agent”), pursuant to which the Company engaged FT Global as the exclusive placement agent in connection with the Offerings. The Placement Agent agreed to use its reasonable best efforts to arrange for the sale of the Shares, the pre-funded warrants and the private warrants under the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash placement agent fee equal to
As additional compensation, the Company also agreed to issue to the Placement Agent or its designees, at the closing of the Offerings, warrants (the “Placement Agent Warrants”) to purchase up to
The summary of warrant activities for the six months ended June 30, 2026 and 2025 were as follows:
| Ordinary Shares Number Outstanding* | Weighted Average Exercise Price* | Remaining Life in Years | ||||||||||
| Warrants Outstanding as of December 31, 2025 | $ | |||||||||||
| Warrants Exercisable as of December 31, 2025 | ||||||||||||
| Warrants Granted | - | |||||||||||
| Warrants Exercised | - | |||||||||||
| Warrants Expired | - | - | - | |||||||||
| Warrants Outstanding as of June 30, 2026 | ||||||||||||
| Warrants Exercisable as of June 30, 2026 (unaudited) | $ | |||||||||||
| Ordinary Shares Number Outstanding* | Weighted Average Exercise Price* | Remaining Life in Years | ||||||||||
| Warrants Outstanding as of December 31, 2024 | $ | |||||||||||
| Warrants Exercisable as of December 31, 2024 | - | - | - | |||||||||
| Warrants Granted | - | - | - | |||||||||
| Warrants Exercised | - | |||||||||||
| Warrants Expired | - | - | - | |||||||||
| Warrants Outstanding as of June 30, 2025* | ||||||||||||
| Warrants Exercisable as of June 30, 2025* (unaudited) | $ | |||||||||||
| * |
F-25
NOTE 14 - TAXES
Corporation Income Tax (“CIT”)
The Company is subject to income taxes on an entity basis on income derived from the location in which each entity is domiciled.
Mingteng International is incorporated in Cayman Islands as an offshore holding company and is not subject to tax on income or capital gains under the laws of the Cayman Islands.
Mingteng International HK is incorporated in Hong Kong as a holding company with no activities. Under the Hong Kong tax laws, an entity is not subject to income tax if no revenue is generated in Hong Kong.
Under the Enterprise Income Tax (“EIT”) Law of the PRC, domestic enterprises and foreign investment enterprises (the “FIE”) are usually subject to a unified
The benefit from (provision for) income taxes consisted of the following:
| For the Six Months Ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Current | ||||||||
| China | - | |||||||
| Deferred | ||||||||
| China | ( | ) | ||||||
| Income tax (benefit) expenses | $ | ( | ) | $ | ||||
The following table reconciles the PRC statutory rate to the Company’s effective tax rate:
| For the Six Months Ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| PRC statutory tax rate | % | % | ||||||
| Additional deduction of research and development expenses | % | % | ||||||
| Non-deductible expenses | ( | )% | % | |||||
| Effect of PRC preferential tax rate | ( | )% | ( | )% | ||||
| Adjustments in respect of current income tax of previous years | ( | )% | ( | )% | ||||
| Effect of different tax rates in the different tax jurisdictions | ( | )% | ( | )% | ||||
| Effective tax rate | % | ( | )% | |||||
F-26
A reconciliation of the PRC statutory income tax rate of
| For the Six Months Ended June 30,2026 | ||||||||
| Amount | Percent | |||||||
| (Unaudited) | (Unaudited) | |||||||
| PRC statutory tax rate | % | |||||||
| Additional deduction of research and development expenses | % | |||||||
| Non-deductible expenses | ( | ) | ( | )% | ||||
| Effect of PRC preferential tax rate | ( | ) | ( | )% | ||||
| Adjustments in respect of current income tax of previous years | ( | ) | ( | )% | ||||
| Effect of different tax rates in the different tax jurisdictions | ( | ) | ( | )% | ||||
| Effective tax rate | % | |||||||
Deferred tax assets and liabilities
Components of net deferred tax assets and liabilities were as follows:
| As of June 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Allowance for credit loss | $ | $ | ||||||
| Inventories valuation allowance | ||||||||
| Operating lease liabilities | ||||||||
| Deferred tax assets | ||||||||
| Right-of-use asset | ( | ) | ( | ) | ||||
| Depreciation | ( | ) | ( | ) | ||||
| Deferred tax liabilities | ( | ) | ( | ) | ||||
| Net deferred tax liabilities | $ | ( | ) | $ | ( | ) | ||
The movement of net deferred tax liabilities and assets were as follows:
| For the six months ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Balance at beginning of the period | $ | ( | ) | $ | ( | ) | ||
| (Provision) reversal | ( | ) | ||||||
| Foreign exchange difference | ( | ) | ( | ) | ||||
| Balance at end of the period | $ | ( | ) | $ | ( | ) | ||
F-27
NOTE 15 - CONCENTRATION OF MAJOR CUSTOMERS AND SUPPLIERS
The top customers who individually represented greater than 10% of the total revenues of the Company for the six months ended June 30, 2026 and 2025 were as follows:
| For the six months ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Customer A | % | % | ||||||
| Customer B | % | % | ||||||
| Customer C | % | * | ||||||
| Customer D | % | * | ||||||
| * |
The top customers who individually represented greater than 10% of the Accounts Receivables of the Company as of June 30, 2026 and as of December 31, 2025 were as follows:
| As of June 30, 2026 | As of December 31, 2025 | |||||||
| (Unaudited) | ||||||||
| Customer A | % | * | ||||||
| Customer B | % | % | ||||||
| Customer C | % | * | ||||||
| * | Indicates below 10%. |
The top suppliers and third-party service providers who individually represented greater than 10% of the total purchase of the Company for the six months ended June 30, 2026 and 2025 were as follows:
| For the six months ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| Supplier A | % | * | ||||||
| Supplier B | % | * | ||||||
| Supplier C | * | % | ||||||
| Supplier D | * | % | ||||||
| * | Indicates below 10%. |
The top suppliers and third-party service providers who individually represented greater than 10% of the Accounts Payables of the Company as of June 30, 2026 and as of December 31, 2025 were as follows:
| As of June 30, 2026 | As of December 31, 2025 | |||||||
| (Unaudited) | ||||||||
| Supplier A | % | * | ||||||
| * | Indicates below 10%. |
F-28
NOTE 16 - COMMITMENTS AND CONTINGENCIES
Contingencies
From time to time, the Company may be subject to certain legal proceedings, claims and disputes that arise in the ordinary course of business. Amounts accrued, as well as the total amount of possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements. As of June 30, 2026, the Company has no outstanding litigation.
Foreign currency risk
The RMB is not a freely convertible currency. The State Administration for Foreign Exchange, under the authority of the People’s Bank of China, controls the conversion of RMB into foreign currencies. The value of the RMB is subject to changes in central government policies and international economic and political developments affecting supply and demand in the China Foreign Exchange Trading System market.
NOTE 17 - SEGMENT REPORTING
ASC 280, “Segment Reporting,” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational structure as well as information about geographical areas, business segments and major customers in financial statements for details on the Company’s business segments.
Based on the management’s assessment, the Company determined that it has only
All of the Company’s long-lived assets are located in the PRC. All of the Company’s products and services are sold or provided in the PRC.
NOTE 18 - SUBSEQUENT EVENTS
On August 20, 2026, the Company registered for resale by the Selling Shareholders up to an aggregate of
On October 6, 2026, the Company entered into a share transfer agreement with Mr. ZHENG Delin and HK Phoenix Gateway Alliance Limited (the “Target Company”), pursuant to which the Company agreed to acquire
The Company evaluated subsequent events through November 13, 2026, the date of the issuance of the unaudited interim condensed consolidated financial statements. Except as disclosed above, the Company did not identify any subsequent events that would have required adjustment to, or disclosure in, these unaudited interim condensed consolidated financial statements.
F-29